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ABSTRACT 
Elucidating the Role of Endocytosis in cAMP-dependent Transcription 
Grace Eulan Peng 
 
There is a growing body of evidence from the last decade that supports the ability of G protein-
coupled receptors (GPCRs) to signal from the endosome. With examples of different subtypes (Gs, 
Gi, Gq) of GPCRs now recognized with this ability, we still have much to learn about the role of the 
endosomal signal. This work explores how endocytosis selectively promotes cAMP-dependent 
transcription by studying a Gs-coupled GPCR, the beta-2 adrenergic receptor (β2AR). To begin to 
investigate the mechanism of how the endosome signal is selective for transcription, I utilized 
recently developed tools including a cAMP fluorescence biosensor, and a knock-in cell line 
endogenously expressing fluorescently labeled protein kinase A catalytic subunit (PKAcat). I 
examined the effects of endocytic blockade on each step of the cAMP signaling cascade using 
primarily spinning disk confocal microscopy, genetic manipulations, biochemical and molecular 
biology methods. In this study we found that endocytosis greatly affected PKAcat nuclear 
accumulation, and that the accumulation in the nucleus was necessary for cAMP-dependent 
transcription of PCK1. 
 
Because this is still a relatively new area of GPCR cell biology, many questions remain 
unanswered, including how does endocytosis affect the functional relationship between two 
receptors? β2ARs, known to signal from the endosome, have an antagonistic relationship with the 
M2 muscarinic acetylcholine receptor (M2R). These Gs- and Gi-coupled receptors, respectively, 
control the overall cAMP produced in the cell by stimulating or inhibiting the cAMP producing 
 viii 
enzyme. The functional relationship between these two receptors are a great example for studying 
the effects of endocytosis on integrative cellular signaling. This work explored the relationship 
between the β2AR and M2R both by examining the trafficking of each receptor and by registering 
the endosomal signal of the β2AR, cAMP-dependent transcription. I utilized already established 
imaging and molecular biology methods to probe the effect of M2R inhibition on β2AR-stimulated 
cAMP signaling. I additionally generated modified constructs complementary to existing nanobody 
biosensors to detect activated states of the M2R and Gαi protein. This work found that it was not 
necessary for M2R to undergo endocytosis in order to inhibit β2AR cAMP-dependent transcription. 
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Chapter 1: Introduction 
 
He who cannot draw on three thousand years is living from hand to mouth. 
Johann Wolfgang von Goethe 
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1.1 Overview 
One of first things I learned was that the G protein-coupled receptor (GPCR) field is extremely well 
studied and well established. It is possible that I did not appreciate that many of the components 
that I have been studying are so well described and their processes so well characterized. β2AR, 
aside from rhodopsin, was one of the early GPCRs studied and used as a model GPCR to 
understand GPCR trafficking and signaling. Protein Kinase A is the first protein kinase described, 
and CREB is one of the first transcription factors to be well characterized. Each of these have such 
a long history, that I will not be able to cover here in any sort of breadth.  
 
This dissertation focuses on understanding endosomal signaling, the mechanism in which it occurs 
and the cellular consequences of signaling from the endosome. The following introduction 
attempts to provide some background and context on G protein-coupled receptors function, 
signaling and trafficking; the emergence of endosomal signaling for GPCRs; a key player in the 
cAMP signaling cascade, protein kinase A; and the model receptors studied, the beta-2 adrenergic 
receptor and the M2 muscarinic acetylcholine receptor.   
 
  
 3 
1.2 The importance of being G protein-coupled receptors 
Cellular signaling is an important process that allows cells to communicate with each other, as well 
as for a single cell to communicate what it senses in its extracellular environment. Cells sense their 
extracellular environment via external stimuli and transmit signals to mediate a proper response. 
Many of these responses are controlled by G protein-coupled receptors (GPCRs). G protein-
coupled receptors (GPCRs) are an important class of receptors responsible for regulating many 
important processes, including cell migration, sight, taste, and smell (Pierce et al., 2002). These 
receptors are also known as serpentine receptors or seven transmembrane receptors (7TM) as 
they snake through the membrane seven times (Pierce et al., 2002). This large superfamily of 
protein receptors is one of the largest classes of pharmaceutical drug targets. 
 
Classically, to initiate an intracellular signal, a 
ligand binds the GPCR on the extracellular 
surface, and induces a conformational 
change to activate the receptor (Figure 1.1a) 
(Weis & Kobilka, 2018). The activated GPCR 
acts as a guanine nucleotide exchange factor 
to activate the corresponding heterotrimeric 
G protein (Gαβγ) through exchange of GDP 
for GTP on Gα. Activated Gα protein 
dissociates from Gβγ, and each component 
can interact with effector proteins to 
propagate the signal response through 
downstream signaling cascades.  
 
Figure 1.1 GPCR signaling cascade 
a. Ligand (blue hexagon) binds to a GPCR on the extracellular 
face. The GPCR is activated and activates the G protein. The 
G protein interacts with the effector protein, which in turn 
stimulates the production or release of a second messenger. 
b. Gs and Gi GPCR subtypes are activated by their 
corresponding ligands (blue hexagon and green star). The 
corresponding G proteins are activated and interact with the 
effector protein adenylyl cyclase to modulate the production of 
the second messenger, cAMP. Gs coupled receptors stimulate 
adenylyl cyclase while Gi coupled receptors inhibit adenylyl 
cyclase to increase or decrease cAMP production respectively. 
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There are multiple GPCR subtypes which couple to different G proteins (e.g. Gαs, Gαi/o, Gαq/11, 
Gα12/13) all of which can mediate distinct responses by interacting with different effector proteins 
such as adenylyl cyclases (ACs), phospholipases, phosphodiesterases (PDEs) and ion channels 
(Pierce et al., 2002). Two subtypes, Gαs and Gαi, can interact with adenylyl cyclases to control 
cAMP production (Figure 1.1b) (Alberts et al., 2002). Gαs stimulates while Gαi inhibits adenylyl 
cyclase to increase and decrease cyclic adenosine monophosphate (cAMP) production.  
 
cAMP acts as a second messenger in the Gαs coupled receptor signaling pathway to promote 
intracellular signaling and is regulated by adenylyl cyclases and phosphodiesterases for its 
synthesis and degradation, respectively (Pierce et al., 2002). One important function of cAMP is to 
activate a downstream enzyme in the signaling cascade, protein kinase A (PKA). Activated PKA 
phosphorylates many substrates including the transcription factor cAMP response element-binding 
protein (CREB) to promote the transcription of genes with cAMP responsive element (CRE) sites.  
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1.3 GPCR trafficking and signaling and the emergence of endosomal signaling 
Agonist binding to a GPCR activates the 
receptor and initiates intracellular 
signaling. To turn off or attenuate the G 
protein signaling response, GPCRs 
undergo a process known as 
desensitization (Figure 1.2). First, 
receptors are phosphorylated by G 
protein-coupled receptor kinases 
(Chuang et al., 1996; Pitcher et al., 
1998). Phosphorylation of the receptor by GRKs increases the affinity for the protein arrestin, 
binding arrestin “arrests” GPCR signaling (Chuang et al., 1996; Gurevich & Gurevich, 2006). These 
steps are essential for GPCR signaling shut off at the plasma membrane. Some GPCRs, can then 
undergo agonist-induced internalization by associating with the clathrin adaptor protein AP2 and 
clathrin in clathrin coated pits (Mellman, 1996). Dynamin assembles a ring at the neck of the 
clathrin coated pit, and through scission, endosomes are pinched off the plasma membrane and 
trafficked intracellularly (Kaksonen & Roux, 2018).  
 
Internalization removes receptors from the plasma membrane, temporarily reducing the number of 
receptors able to bind agonist and signal. In endosomes, receptors may remain phosphorylated, 
therefore unable to couple to and activate G proteins (Tran et al., 2007). Additionally, as 
endosomes intracellularly traffic, the lumen acidifies and destabilizes the agonist bound to the 
receptor (Murphy et al., 2009). Through the processes of desensitization and internalization, all of 
these effects reduce the ability of receptors to signal. Because the desensitization process 
 
Figure 1.2 Desensitization and sequestration of GPCRs 
GRKs phosphorylate GPCRs which recruit arrestin (green). After 
arrestin binding, GPCRs enter clathrin coated pits (yellow). As 
clathrin coated pits grow, Dynamin (teal) forms a ring around the 
neck to prepare for scission and vesicles pinch off. The chemical 
inhibitors PitStop, Dynasore and Dyngo-4A inhibit clathrin and 
dynamin. Genetic manipulations block endocytosis through clathrin 
depletion by siRNA for CHC17 and through a dominant negative 
mutant of dynamin.  
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precedes receptor internalization, GPCRs have classically though to be inactive in endosomes. 
Until recently, endosomal signaling by GPCRs had not been thought to occur because of the 
classical paradigm of internalization as a consequence of a signaling shut off mechanism. 
 
Support for GPCR signaling from the endosome began about a decade ago. Evidence that 
signaling was not limited at the plasma membrane, but also extended to the endosome was first 
found in yeast (Slessareva et al., 2006). This study used a knock out yeast strain screen aimed at 
finding candidate Gpa1 (Gα) effectors by studying mating responses. The screen identified proteins 
that interact with Gpa1 to function at the endosome instead of at the plasma membrane.  
 
Initial evidence supporting GPCR endosomal signaling in mammalian cells began with the 
sphingosine-1 phosphate receptor (Mullershausen et al., 2009), and the polypeptide hormone 
receptors, thyroid stimulating hormone receptor (TSHR, Calebiro et al., 2009) and parathyroid 
hormone receptor (PTHR, Ferrandon et al., 2009). These initial reports showed a persistent 
signaling dependent on G proteins. This persistent signal continuing long after what the acute 
plasma membrane response. Additionally, this persistent or sustained signal was difficult to reverse 
after washout or ligand removal. These results supported the hypothesis of G protein activated 
signaling from the endosomes. Most of the evidence supporting GPCR endosomal signaling has 
been found with Gαs coupled receptors (Calebiro et al., 2009; Feinstein et al., 2013; Ferrandon et 
al., 2009; Irannejad et al., 2013; Kotowski et al., 2011; Lyga et al., 2016; Merriam et al., 2013; 
Yarwood et al., 2017), but there is growing support of endosomal signaling for multiple subtypes 
including Gαi and Gαq (English et al., 2018; Gilliland et al., 2013; Jensen et al., 2017; 
Mullershausen et al., 2009; Stoeber et al., 2018).  
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Several types of experimental methods and assays have been used to probe endosomal signaling 
in different GPCRs. One method blocks endocytosis by inhibiting clathrin and dynamin using either 
chemical inhibitors such as PitStop, Dynasore, Dyngo-4A, or genetic manipulations by siRNA 
depletion of clathrin or dominant negative dynamin (K44A or K44E, Figure 1.2) (Hinshaw, 2000; 
Mccluskey et al., 2013; Vassilopoulos et al., 2009; von Kleist et al., 2011). Another method, when 
possible, has been to use a combination of agonist and antagonist with different membrane 
permeabilities to determine from where the signal originates (i.e. agonist followed by membrane 
impermeable antagonist to eliminate the plasma membrane signal) (Ferrandon et al., 2009; Stoeber 
et al., 2018). Additionally, an agonist washout method has also been used to identify persistent or 
sustained signaling in GPCRs through the observation of slow or a lack of signaling reversal 
(Calebiro et al., 2009; Ferrandon et al., 2009). Lastly, newer methods have been developed to 
probe endosomal signaling. These methods have adapted single chain and single domain camelid 
antibodies known as nanobodies. Nanobodies are conformationally sensitive antibodies that have 
been used to detect activated GPCRs and G proteins (Rasmussen, Choi, et al., 2011; Rasmussen, 
DeVree, et al., 2011). These nanobodies have been adapted to be conformational biosensors for 
microscopy by the addition of a fluorescent protein. These nanobody biosensors have proven 
particularly useful in detecting where activated GPCR and G proteins exist in the cell after agonist 
addition, as nanobody biosensors have detected activated GPCRs and G proteins at the plasma 
membrane, the endosome and also the Golgi (Irannejad et al., 2017, 2013; Stoeber et al., 2018). 
 
In the past decade GPCR endosomal signaling through G protein activation has become readily 
recognized. Much of the work that has been done to characterize and describe endosomal 
signaling comes from studies on three receptors, TSHR, PTHR and β2AR (Calebiro et al., 2009; 
Feinstein et al., 2011; Ferrandon et al., 2009; Godbole et al., 2017; Irannejad et al., 2013; Jean-
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Alphonse et al., 2016; Tsvetanova et al., 2017; Tsvetanova & von Zastrow, 2014). Work on these 
three receptors have shown multiple mechanisms of propagating the signal initiated from the 
endosome. Much remains unknown as we continue to uncover the mechanisms and importance 
of signaling from the endosome. 
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1.4 Beta-2 Adrenergic Receptors 
The beta adrenergic receptors (βARs) are a family of receptors that respond to catecholamines and 
are important in mediating a wide range of physiological responses in the cardiovascular, 
pulmonary, metabolic and central nervous systems. Within the family are three subtypes of 
receptors, the β1ARs, β2ARs, and β3ARs (Wallukat, 2002). In general, the βARs have been well 
studied, and the β2AR is a prototypical GPCR whose trafficking and signaling has been extensively 
studied and well characterized.  
 
β2ARs are known to undergo desensitization followed by receptor internalization (Wallukat, 2002). 
After internalization, receptors can recycle back to the plasma membrane or traffic to the lysosome 
for degradation after prolonged exposure to agonist. β2ARs primarily couple to Gαs protein to 
initiate the cAMP signaling cascade as previously described (Figure 1.1b) (Wallukat, 2002). This 
signaling, classically thought to occur at the plasma membrane, was recently found to exist at the 
endosomal as well. The work done to investigate and describe β2AR endosomal signaling 
benefitted from the development of new tools. 
 
The first evidence for β2AR endosomal signaling used a combination of signaling and microscopy 
assays with newly developed conformational biosensors. These conformation biosensors 
comprised of a conformationally sensitive camelid antibodies, termed nanobodies, fused to a 
fluorescent protein. Previously, the nanobodies had been used to stabilize activated receptor and 
G protein states for x-ray crystallography (Rasmussen, Choi, et al., 2011; Rasmussen, DeVree, et 
al., 2011). These conformational biosensors were now useful in detecting where activated GPCRs 
and G proteins exist in the cell. Nb80 and Nb37, the nanobodies that detect activated β2AR and 
Gαs protein were present at both the plasma membrane, and subsequently at the endosome after 
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agonist addition (Irannejad et al., 2013). These results suggested that the β2AR is capable of 
signaling from the endosome as it was in an activated state at the endosome and the G protein 
which it couples to was activated as well. These results coupled to a moderate reduction in cAMP 
production when the β2AR was stimulated and endocytosis was blocked, suggested that the 
endosome contributed to the cellular cAMP levels.  
 
This study provided evidence for β2AR endosomal signaling, but the consequences of β2AR 
remained unknown. Another study investigated downstream signaling of β2AR by comparing the 
transcriptional profiles using microarrays between samples when β2AR was stimulated and 
endocytosis was allowed vs blocked (Tsvetanova & von Zastrow, 2014). As a result, a suite of 
genes was discovered to be induced when endocytosis was allowed. These results suggested that 
β2AR signaling has an endocytic-dependent transcriptional component. To confirm these results, 
an orthogonal approach of generating cAMP through bacterial-derived photoactivated adenylyl 
cyclase (bPAC) was used to interrogate the spatial component of cAMP signaling. bPAC was 
directed to different locations in the cell (plasma membrane, endosome, cytoplasm) and was light 
activated to produce cAMP. The endosomal and cytoplasmic bPAC but not the plasma membrane 
bPAC significantly induced the endocytosis-sensitive transcriptional targets previously found by 
microarray. This result corroborated the idea that β2AR endosomal signaling can confer a specific 
selective effect on the downstream signaling response. 
 
Taken together, these results suggest that β2AR signals from the endosome with a moderate 
amount of cAMP that results in a significant transcriptional response. Exploration in understanding 
how such signaling selectivity is conferred will be important in understanding β2AR endosomal 
signaling and the importance in overall cellular signaling.  
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1.5 Protein Kinase A 
One of the important players in the cAMP signaling cascade is cAMP-dependent protein kinase A 
(PKA). PKA is activated after binding to cAMP, after activation PKA can then go on to 
phosphorylate many substrates to propagate the signaling response which is responsible for the 
regulation of metabolism, transcription, cell growth and differentiation (Skålhegg & Tasken, 2000). 
The PKA holoenzyme is tetrameric enzyme composed of two regulatory (PKAreg or R) and two 
catalytic (PKAcat or C) subunits (Taylor, Kristoffer). PKAreg contains two cAMP binding sites and 
associates with A kinase anchoring proteins (AKAPs) to localize PKA holoenzyme to different 
subcellular locations in the cell (Søberg & Skålhegg, 2018; Taylor et al., 2012). After cAMP binds 
PKAreg, this induces a conformational change in PKAreg, as a result, PKAcat is then released and 
activated (Zhang et al., 2012). 
 
There are two primary types of PKA holoenzyme, PKA type I (PKAI) and PKA type II (PKAII), each 
are designated by which PKAreg (RI or RII respectively) exists in the holoenzyme (Søberg & 
Skålhegg, 2018). Of these PKA regulatory subunit types, each have two isoforms – RIα and RIβ, 
RIIα and RIIβ (Carnegie et al., 2009; Scott et al., 1990; Wu et al., 2007). PKAI and PKAII are known 
to associate with different proteins, localizing PKA to different subcellular locations (Autenrieth et 
al., 2016; Beene & Scott, 2007; Calejo & Taskén, 2015). One way this differential localization is 
thought to occur is through AKAPs as AKAPs bind to RII with higher affinity compared to RI (Carr 
et al., 1991). RI is primarily found to be diffuse in the cytoplasm of the cell, but RI and dual-specific 
AKAPs may exist (Day et al., 2011; Dema et al., 2015; Jarnaess & Taskén, 2007). There are also 
two primary PKAcat isoforms, Cα and Cβ. PKAcatα is the primary form of catalytic subunit in the 
cell and ubiquitously expressed in many tissues (Uhler et al., 1986). Recent work estimated 
concentrations of PKA subunits in HEK293T cells and found approximately 2 μM PKAreg (RI and 
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RII) and 0.2 μM PKAcat (Walker-Gray et al., 2017). Additionally, PKAreg binds PKAcat with sub-
nanomolar Kd (Kim et al., 2005; Wu et al., 2007). 
 
In understanding how PKAcat is spatially restricted, contradictory reports arose in whether or not 
PKAcat is released from PKAreg after cAMP elevation. These studies propose different possibilities 
in how PKAcat signaling is spatially restricted (Smith et al., 2017; Tillo et al., 2017; Walker-Gray et 
al., 2017). Two of the studies agree that PKAcat is released from PKAreg after cAMP elevation, but 
myristoylation of PKAcat allows it to associate with the membrane to preferentially phosphorylate 
substrates there (Tillo et al., 2017; Walker-Gray et al., 2017). Additionally, the spatial restriction of 
PKAcat could be explained by the increase in recapture by PKAreg because of the stoichiometric 
ratio between PKAreg and PKAcat (~10:1) (Walker-Gray et al., 2017). Lastly, an alternative 
mechanism was proposed where PKAcat remains tethered to PKAreg, thereby heavily restricting 
the substrates PKAcat can phosphorylate (Smith et al., 2017). It is possible that these mechanisms 
may not be mutually exclusive and could exist in the same cell. Which mechanisms occur may be 
dependent on the subcellular locations of PKAcat. 
 
In addition to the PKAcat activity in the cytoplasm, PKAcat has also been found in the nucleus. 
PKAcat activity in the nucleus has been shown to be important for cAMP-dependent transcription 
through the phosphorylation of cAMP regulatory element binding protein (CREB) at Ser133. 
PKAcat has been found to diffuse into the nucleus (Harootunian et al., 1993). Additionally, AKAP95 
microdomains in the nucleus contains both PKAcat and PDE4 (Clister et al., 2019). In this case 
nuclear PKAcat to mediate a response, high levels of cAMP are needed to overcome degradation 
by PDEs.  
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Although much work has been done to understand how PKAcat enters the nucleus, no nuclear 
localization sequence has been found. Other than simple diffusion, two other components for 
nuclear localization have been suggested. First, PKAcat has been shown to bind A kinase 
interacting protein (AKIP1) which has been shown to target PKAcat into the nucleus (Sastri et al., 
2005). Additionally, a posttranslational modification has been shown to reduce nuclear levels of 
PKAcat. PKAcat Asn2 has been found to undergo deamidation through a non-enzymatic beta 
aspartyl shift mechanism (Gesellchen et al., 2006; Wright, 1991). Higher levels of PKAcat have 
been found in the nucleus when the second residue of PKAcat remains as Asn and not Asp 
(Pepperkok et al., 2000). 
 
Although the mechanism for PKAcat remains unclear, nuclear PKAcat export is well described. In 
the nucleus, PKAcat activity is regulated by protein kinase inhibitor (PKI). Three isoforms of PKI 
exist, PKIα, PKIβ, PKIγ, and inhibit PKAcat by acting as a pseudosubstrate (Gamm & Uhler, 1995; 
Herberg et al., 1999). PKI has a well described nuclear export sequence, and after binding PKAcat, 
PKI transports PKAcat out of the nucleus into the cytoplasm (Wen et al., 1995). 
 
PKAcat has been implicated as an important key player in intracellular signaling. In addition to the 
plasma membrane, PKAcat exists in many subcellular locations, such as the Golgi which may 
poise important signaling components in the right location to promote endosomal signaling 
(Godbole et al., 2017). How such a diffusible protein is able to help propagate a specific response 
remains unexplored. 
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1.6 M2 Muscarinic Acetylcholine Receptors 
The muscarinic acetylcholine receptor family of GPCRs regulate important basic physiological 
functions including many processes in the central nervous system and autonomic effector organs 
(Bubser et al., 2012; Caulfield, 1993). There are five subtypes of the muscarinic acetylcholine 
receptor family, M1-5, all of which signal through heterotrimeric G proteins and initiate downstream 
signaling cascades through second messengers (Bubser et al., 2012; Caulfield, 1993; Wess et al., 
2007). 
 
After activation with acetylcholine, M2R activates Gαi which inhibits the production of cAMP 
through adenylyl cyclase and Gβγ activates G protein inward rectifying potassium channels (GIRKs) 
(Bubser et al., 2012; Felder, 1995). Like many GPCRs, M2Rs are internalized following agonist-
induced activation (Robin Pals-Rylaarsdam et al., 1997; Reiner & Nathanson, 2008). This process 
has been traditionally preceded with functional desensitization of cellular signaling responses. The 
phosphorylation sites responsible for M2R desensitization and internalization reside in the third 
intracellular loop, removal or mutation of specific Ser/Thr residues blocks desensitization and 
internalization (R. Pals-Rylaarsdam & Hosey, 1997).  
 
Previously, M2Rs have been found to exist in early endosome antigen 1 (EEA1) positive 
endosomes after agonist-induced internalization (Delaney et al., 2002). However, the mechanism of 
how M2R internalizes remains unclear as M2Rs have not been found to internalize through well 
recognized mechanisms. Previous studies have conflicting evidence in determining which 
components are involved in M2R endocytosis. There is some evidence for a caveolin-independent, 
clathrin-independent and dynamin-independent pathway, and therefore a very non-traditional 
pathway (Delaney et al., 2002; Roseberry & Hosey, 2001). A recent study challenges these earlier 
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reports as they find a dependence on clathrin and dynamin for endocytosis (Jones et al., 2006). 
Another clue comes from a study that claims that the clathrin-dependent endocytosis sequence 
can be obscured by a clathrin-independent endocytosis sequence, thereby promoting clathrin-
independent endocytosis of M2R (Wan et al., 2015). Given the conflicting evidence, it is clear that 
there are be several methods of endocytosis for the M2R, and which mechanism for endocytosis 
could be dependent on the cell type. 
 
The M2 muscarinic acetylcholine 
receptors (M2Rs) have important roles in 
the brain including in depression, 
cognition, learning and memory, and is 
additionally known to be important in heart 
function (Bainbridge et al., 2008; Brodde 
& Michel, 1999; Bubser et al., 2012; Dhein et al., 2001; Mysliveček & Trojan, 2003; Wess et al., 
2007). In the heart, M2R is important for regulating contraction strength and heart rate under basal 
conditions and under adrenaline (also known as epinephrine) induced conditions. Upon an 
adrenaline rush, the Gαs coupled receptors, β1 and β2 adrenergic receptors (β1AR and β2AR) 
stimulate stronger contractions (positive inotropy) and faster heart rate (positive chronotropy) 
through AC mediated effects (Figure 1.3) (Brodde & Michel, 1999; Dzimiri, 1999). This process is 
modulated by M2R to return the contraction strength (negative inotropy) and heart rate (negative 
chronotropy) back to the basal level through the inhibition of AC and the activation of GIRK 
channels (Brodde & Michel, 1999; Harvey, 2012). 
 
 
Figure 1.3 M2R and βAR function in the heart 
M2Rs are important in setting the basal heart rate and reducing 
heart rate after βAR induced heart rate increase. 
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The evidence for GPCR endosomal signaling initially began mostly with Gαs coupled receptors but 
has expanded to different GPCR subtypes including Gαi and Gαq. However, whether M2R signals 
from the endosome remains uncertain. Given the important roles M2R plays in many physiological 
processes, it is critical to determine whether M2R signals from the endosome, what its specific 
signaling effects are and how it could contribute to overall cellular signaling. Work with the M2R 
has already provided a nanobody used for the structural determination of the M2R by x-ray 
crystallography (Kruse et al., 2013). Adapting these nanobodies for use as conformational 
biosensors could prove useful in answering these questions. 
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2.1 Abstract 
G protein-coupled receptors are capable of sustaining their signaling response well after 
internalization, where the endosomal signal has been strongly linked to promote gene transcription. 
Inhibition of endocytosis leads to an altered signaling state. How these signals contribute to the 
overall cellular response and how cells distinguish between these signals to provide differential and 
consequential cellular signals remain unanswered. Here, using endogenously expressed beta-2 
adrenergic receptor in HEK293s, we break down the overall cellular cAMP response and find that 
endocytosis promotes nuclear accumulation of protein kinase A catalytic subunit. Without 
endocytosis, this key step and the subsequent signaling events fail to generate the profound 
transcriptional response. 
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2.2 Introduction 
GPCRs comprise nature’s largest family of signaling receptors, which regulate essentially every 
physiological process and consequently are important drug targets (Allen & Roth, 2011; Hauser et 
al., 2017). A considerable amount is known about biochemical and biophysical aspects of GPCR 
function and regulation, but how GPCR-mediated signaling is organized and integrated at the level 
of intact cellular physiology remains relatively poorly understood. An interesting recent advance is 
that ligand-induced activation of GPCRs and cognate G proteins, although long believed to be 
restricted to the plasma membrane, can also occur from endosomes (Lobingier & von Zastrow, 
2019; Tsvetanova et al., 2015). A fundamental question raised by this advance is what significance 
the additional spatial dimension of signaling afforded by endosomal activation has on integrated 
cellular function. 
 
G protein activation by GPCRs in endosomes was initially recognized through studies of signaling 
initiated by a polypeptide hormone-activated GPCR, Ste2p, in yeast (Slessareva et al., 2006). 
Ste2p initiates G protein (Gpa1)-dependent activation of protein kinase cascades from the plasma 
membrane and then is internalized, engaging in endosomes a variant Gpa1-containing heterotrimer 
that stimulates local generation of the membrane-delimited lipid mediator, PtdIns(3)P. Endosomal 
activation of GPCR-G protein signaling has been described most extensively in mammalian cells 
through the study of receptors that couple via heterotrimeric Gs to the generation of cAMP, which 
is soluble and diffusible rather than membrane-delimited (Calebiro et al., 2009; Ferrandon et al., 
2009; Irannejad et al., 2013; Kotowski et al., 2011; Lyga et al., 2016). Nevertheless, initiating cAMP 
synthesis from endosomes relative to the plasma membrane can produce different cellular effects. 
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One strategy for producing a different effect through endosomal generation of a diffusible mediator 
is to use the location of synthesis secondarily, by changing the amount or timing of overall 
mediator production. Mammalian polypeptide hormone receptors provide a clear example because 
they produce a transient cAMP elevation when activated at the cell surface and a sustained 
elevation after endocytosis (Calebiro et al., 2009; Ferrandon et al., 2009). An alternative strategy is 
to use the altered location of mediator production as a primary determinant of signaling specificity 
from endosomes, separately from changes in the overall amount or timing of mediator produced. 
However, in contrast to membrane-delimited responses for which location is inherently critical, the 
cAMP cascade involves diffusible mediators so it is not known how location could possibly be a 
salient variable. 
 
cAMP-dependent transcriptional signaling by the human beta-2 adrenergic receptor (β2AR) 
provides an interesting example. β2ARs activate Gs-dependent production of cAMP from the 
plasma membrane and additionally from endosomes after ligand-induced internalization mediated 
by receptor clustering in clathrin-coated pits followed by dynamin-dependent vesicle formation (von 
Zastrow & Kobilka, 1992; Zhang et al., 1996). However, unlike polypeptide hormone receptors that 
linger in the endocytic network and produce a sustained cAMP response after endocytosis, β2ARs 
recycle rapidly and produce a transient cAMP response both from the plasma membrane and from 
endosomes (Calebiro et al., 2009; Ferrandon et al., 2009; Irannejad et al., 2013). Further, inhibiting 
endocytosis by manipulating clathrin abundance or dynamin activity produces only a small 
inhibition of signaling measured the level of global cAMP elevation (Irannejad et al., 2013). 
Nevertheless, when signaling is measured at the level of cAMP-responsive gene expression, 
endocytic blockade produces a strong inhibition (Tsvetanova & von Zastrow, 2014). Moreover, the 
subcellular location of cAMP production has been shown to be a primary determinant of the 
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cAMP-dependent transcriptional response, separately from additional effects on the overall amount 
of cytoplasmic cAMP produced (Tsvetanova & von Zastrow, 2014). 
 
How such ‘location-aware’ downstream transduction is conveyed through the β2AR-initiated 
cAMP cascade remains unclear. Additionally, transcriptional signaling initiated by endosomal 
activation of the cAMP cascade is a particularly interesting example of location-dependent 
signaling because cAMP is not the only potentially diffusible mediator in this cascade. The other is 
the catalytic subunit of protein kinase A (PKAcat), which can be unleashed upon binding of cAMP 
to regulatory subunits in PKA holoenzyme to operate as a diffusible and autonomously active 
kinase (Søberg & Skålhegg, 2018). Thus transcriptional control via the cAMP cascade conveys 
location-aware information through two potentially diffusible mediators. 
 
Yet another interesting property of cAMP-dependent transcriptional signaling is its distance scale. 
Localized operation of the cAMP cascade is well described in the cytoplasm and plasma 
membrane, where specificity of downstream coupling can be achieved by enforced proximity 
through protein scaffolding or membrane tethering that positions effectors adjacent to sites of 
diffusible mediator production (Agarwal et al., 2016; Esseltine & Scott, 2013; Lohse et al., 2017). 
However, this strategy is typically limited to a near-molecular distance scale because, beyond this 
distance, concentration elevations that result from local mediator production are largely dissipated 
as a consequence of rapid diffusion. cAMP-dependent transcription presents a unique challenge 
because a key effector in this pathway, the cAMP response element binding protein (CREB), is 
restricted to the nucleus by constitutive association with chromatin and cAMP response element 
(CRE) motifs present in cognate gene promoters (Montminy & Bilezikjian, 1986). Accordingly, 
location-aware information conveyed by the cAMP cascade must span a considerable distance 
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and cross two subcellular compartments that are separated by a double-layered nuclear 
membrane. 
 
Here we investigate how endocytosis achieves location-aware transcriptional control in a well-
established cellular model system, with all signaling components expressed at endogenous levels 
and using activation by endogenous receptors. We delineate a cellular strategy in which cAMP acts 
largely as a global mediator and nuclear entry of PKAcat conveys information about location, with 
these discrete biochemical information streams operating in concert to specify the location-aware 
downstream transcriptional response. 
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2.3 Results 
Limited effect of endocytosis on global cytoplasmic cAMP 
We focused on human embryonic kidney (HEK293) cells as a model system because these cells 
endogenously express β2ARs that are coupled via Gs to stimulation of the cAMP/PKA cascade, 
mediate sequential phases of β2AR-Gs activation in the plasma membrane followed by 
endosomes, and require endogenous β2AR-Gs activation in endosomes to produce a full 
transcriptional response (Irannejad et al., 2013; Tsvetanova & von Zastrow, 2014; Violin et al., 
2008). In principle, endocytosis could promote transcription through effects on the overall amount 
of cellular cAMP production, its timing or location. Transcriptional control in HEK293 cells was 
shown previously to depend on the subcellular location of cAMP production, independently of 
changes in overall amount, but it remains unknown if endosomal β2AR-Gs activation has additional 
effects on amount or timing that contribute to downstream pathway selectivity (Tsvetanova & von 
Zastrow, 2014). Further, recent studies differ in whether endocytosis has any effect on the amount 
or timing of global cAMP elevation. Thus we began by investigating this question. 
 
We previously used a luminescence-based cAMP biosensor to examine cytoplasmic cAMP 
elevation elicited by endogenous Β2AR activation in living cells, at 37˚C and in the absence of 
phosphodiesterase inhibitors (Goulding et al., 2018; Irannejad et al., 2013). We improved this assay 
by adding an IRES-linked renilla luciferase cassette to enable normalization for possible well-to-well 
differences in cell number or transfection efficiency (see Methods). Application of the Β2AR agonist 
isoproterenol (Iso) at 100 nM (a near-saturating concentration) produced a robust increase in the 
normalized luminescence response reporting cytoplasmic cAMP elevation (Figures 2.1a & S2.1a). 
Endocytic blockade imposed by over-expression of a dominant negative mutant version of 
dynamin (Dyn1-K44E, van der Bliek et al., 1993), whose effectiveness we verified in our system 
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(Figures S2.1b&c), caused a small but consistent reduction of the global cAMP response (Figures 
2.1a & S2.1a). We observed similar results using two independent strategies to impose endocytic 
blockade, RNAi-mediated depletion of clathrin heavy chain and chemical inhibition of dynamin 
using Dyngo-4A (Figures S2.1b-d) (Mccluskey et al., 2013; Vassilopoulos et al., 2009). In contrast 
to the modest effect of endocytic blockade on overall cAMP elevation, the downstream 
transcriptional response assessed using endogenous PCK1 as a validated cAMP/PKA-responsive 
target gene was profoundly inhibited (Figures 2.1b & S2.1e). 
 
We considered that even a small inhibition of upstream cytoplasmic cAMP elevation could explain 
a much larger effect on the downstream transcriptional response if there is sufficient non-linearity in 
the transduction cascade. To test this, we reduced cytoplasmic cAMP elevation independently of 
endocytic manipulations by decreasing the concentration of isoproterenol applied to activate 
endogenous Β2ARs. Remarkably, even when applied at very low concentrations that produce an 
amount of overall cytoplasmic cAMP elevation substantially lower than that produced by 100 nM 
isoproterenol with endocytic blockade (Figures 2.1c & S2.1f), the downstream transcriptional 
response was still higher than observed in the presence of 100 nM isoproterenol with endocytic 
blockade (Figure 2.1d). 
 
We compared different isoproterenol doses and the different methods of endocytic blockade by 
looking at how the overall cAMP and PCK1 transcriptional responses were affected by these 
conditions (Figure 2.1e). We found that in the presence of endocytosis (100 nM, 10 nM, 1 nM Iso) 
the PCK1 response was stronger than the cAMP response. In contrast, we saw the opposite with 
the endocytic blockade methods (mutant dynamin, clathrin RNAi depletion, dynamin chemical 
inhibitor), where the cAMP response was stronger than the PCK1 response. These results suggest 
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that the overall cAMP elevation was not primarily responsible for the endocytic-dependence of 
Β2AR-stimulated PCK1 transcription. 
 
We used the luminescence biosensor to determine the maximal response from each condition as it 
has been widely used before. To detect the kinetics of the cAMP response, we applied a 
fluorescence-based cAMP biosensor that achieves similarly high sensitivity as the luminescence 
biosensor but reports directly through an intramolecular conformational change independent of 
other cellular reactions. This probe, generated by fusing a circularly permuted green fluorescent 
protein variant to a high-affinity cAMP-binding domain (see Methods), resolved the endogenous 
cAMP response into two kinetic phases. An initial, transient peak of high cAMP concentration was 
observed immediately after isoproterenol application and decayed over 10-15 min. The 
cytoplasmic cAMP elevation observed during this ‘peak phase’ was sufficient to saturate the 
biosensor response (defined using forskolin and the PDE inhibitor IBMX to drive supra-physiologic 
cAMP elevation). Based on in vitro characterization of the sensor, we estimated this peak 
cytoplasmic cAMP concentration to briefly exceed ~5 μM (Figure S2.1g). After the transient peak 
decayed, a second phase of the response was observed in which cytoplasmic cAMP remained 
moderately elevated and still dependent on agonist because it returned to baseline after antagonist 
(Alp) application (Figure 2.1f, teal curve). The cAMP concentration achieved during this ‘plateau 
phase’ was substantially lower than in the peak phase and, based on in vitro characterization of 
the sensor, we estimated to be in the range of 100-500 nM (Figure S2.1g). Endocytic blockade 
caused a reliable but partial reduction in the magnitude of cytoplasmic cAMP elevation observed in 
the peak phase of the endogenous Β2AR-Gs response but it had little effect on the plateau phase 
(Figure 2.1f, magenta curve) or on the overall timing of the cAMP response (Figure S2.1h).  
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These results, taken together, indicate that endocytosis indeed increases the global cytoplasmic 
cAMP response elicited by endogenous Β2AR-Gs activation. However this effect is modest when 
compared to the much larger effect of endocytosis on downstream transcription, and is limited 
primarily to the early peak of cytoplasmic cAMP elevation that dissipates before the transcriptional 
response. Thus our results add further support to the previous conclusion that endosomal 
activation of endogenous Β2AR-Gs promotes transcriptional signaling primarily by moving the 
location of upstream cascade activation, rather than by increasing the amount of timing of overall 
cytoplasmic cAMP elevation. They also indicate that the ‘location-aware’ nature of the 
transcriptional response elicited by Β2AR-Gs activation must originate at a stage in the signaling 
pathway downstream of cAMP production itself, motivating us to extend our search. 
 
Endocytosis is not required for cytoplasmic PKAcat mobilization 
We next investigated PKA because this signaling node is immediately downstream of cAMP 
production, and PKA is directly activated by cAMP. We focused on the catalytic subunit of PKA 
(PKAcat) because it possesses the kinase activity required to drive downstream transcription. 
PKAcat can be physically unleashed as a diffusible and autonomously active kinase after cAMP 
binds to PKA regulatory subunits (PKAreg) (Hagiwara et al., 1993; Søberg & Skålhegg, 2018). 
 
To visualize PKAcat in living cells and at endogenous levels, we applied a previously described 
strategy using CRISPR-based genome editing and split fluorescent protein tagging to label the 
native PRKACA gene with mNeonGreen2 (mNG2, Figures 2.2a & S2.2a) (Feng et al., 2017; 
Kamiyama et al., 2016). Consistent with previous studies describing fully native PKAcat localization 
in fixed cells, endogenously labeled PKAcat protein (mNG2-PKAcat) was non-uniformly distributed 
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in the cytoplasm of unstimulated cells, with a major fraction of protein concentrated adjacent to the 
nucleus (Figure 2.2b) (Leonetti et al., 2016; Nigg et al., 2000).  
 
In unstimulated cells, mNG2-PKAcat remained non-uniformly distributed in the cytoplasm without 
detectable movement over time (Figure 2.2b, top row of images). In contrast, after adding 
isoproterenol to drive Β2AR-Gs activation, endogenously labeled PKAcat dispersed rapidly in the 
cytoplasm and then returned to a perinuclear distribution pattern similar to that observed in 
unstimulated cells (Figure 2.2b) (Irannejad et al., 2017; Nigg et al., 2000). 
 
Similar results were obtained under conditions of endocytic blockade. PKAcat remained non-
uniformly localized in the cytoplasm in unstimulated cells (Figure 2.2c, top row), and dispersed 
rapidly and then relocalized after application of isoproterenol (Figure 2.2c, bottom row). We 
quantified these results over multiple experiments by determining PKAcat fluorescence intensity as 
a function of time after agonist addition in a region of interest corresponding to the perinuclear pool 
(Figure 2.2d, green oval). The initial phase of PKAcat dispersal throughout the cytoplasm 
decreased labeled PKAcat fluorescence in the perinuclear region, and relocalization was indicated 
by a subsequent increase. This analysis verified pronounced dispersal of the perinuclear pool of 
labeled PKAcat within less than a minute after application of isoproterenol and an apparently 
complete recovery to the pre-stimulation baseline within ~30 minutes, despite agonist still being 
present. Endocytic blockade produced no detectable effect on PKAcat dispersal elicited by 
isoproterenol, and little or no effect on the subsequent relocalization of PKAcat to the perinuclear 
region of the cell after continued agonist exposure (Figures 2.2d & S2.2b). 
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The timing of these events generally mirrored the global cAMP response, with PKAcat dispersing 
throughout the cytoplasm occurring during the peak phase of the cytoplasmic cAMP response and 
relocalizating to the perinuclear pool during the plateau phase. Together, these results indicate that 
PKAcat relocalization in the cytoplasm effectively mirrors the biphasic global cytoplasmic cAMP 
elevation elicited by Β2AR-Gs activation and does not require endocytosis.  
 
Endocytosis promotes CREB phosphorylation 
After failing to discern a large effect of endocytosis on PKAcat localization or redistribution in the 
cytoplasm, we asked if endocytosis affects functional kinase activity in the nucleus. To do so we 
focused on the phosphorylation CREB at Ser133, a consensus site that is essential for the 
transcriptional response (Brindle & Montminy, 1992; Gonzalez & Montminy, 1989; Mayr & 
Montminy, 2001). Phosphorylated CREB (pCREB) was determined as a function of time after 
isoproterenol addition and normalized to total CREB as a loading control. Isoproterenol produced a 
robust increase in this response that peaked within 30 minutes and remained significantly elevated 
for over an hour. Endocytic blockade imposed by K44E mutant dynamin produced a pronounced 
inhibition of this response, suppressing the sustained elevation observed in the response beginning 
at ~30 min and continuing thereafter (Figures 2.3a&b).  
 
Similar results were obtained using clathrin knockdown as an independent genetic method to 
impose endocytic blockade (Figures 2.3c&d). Again, the main effect of endocytic blockade was 
inhibition of CREB phosphorylation detected in the prolonged presence of isoproterenol. Together, 
these results indicate that endocytosis, while having only a modest effect on upstream cAMP 
elevation and no obvious effect on PKAcat localization or redistribution in the cytoplasm, is 
essential for the downstream step of CREB phosphorylation in the nucleus. 
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Endocytosis promotes accumulation of PKAcat in the nucleus 
Having identified phosphorylation in the nucleus as an endocytosis-dependent step in the pathway, 
we next investigated the basis for this effect. Two potential routes for cAMP-dependent 
phosphorylation of nuclear CREB have been described. One route occurs through cAMP-mediated 
dissociation of PKAcat from PKA holoenzyme in the cytoplasm followed by diffusion of unleashed 
PKAcat through the nuclear pore complex (Hagiwara et al., 1993; Harootunian et al., 1993). A 
second route occurs through activation of a discrete pool of PKA holoenzyme that is restricted to 
the nucleus by cAMP that diffuses into the nucleus through nuclear pores (Clister et al., 2019). The 
second route is known to require sustained high levels of cytoplasmic cAMP elevation, which our 
results indicate are not produced by endogenous Β2AR-Gs activation. For this reason, and 
because our imaging data detected PKAcat predominantly in the cytoplasm, we focused on the 
first route. Specifically, we asked if PKAcat undergoes nuclear accumulation in response to 
endogenous Β2AR activation and, if so, whether this cross-compartment accumulation process is 
dependent on endocytosis. 
 
We began by examining native (unlabeled) PKAcat in HEK293 cells, using subcellular fractionation 
to separate nuclei from cytoplasm (Figure 2.4a) followed by immunoblot analysis. Endogenous 
Β2AR activation produced a clearly detectable increase in PKAcat recovered in nuclei, verified 
using endogenous HDAC2 as a nuclear loading control, and this effect occurred with a time course 
paralleling the nuclear pCREB response (Figures 2.4b&c). Significantly, and fully consistent with the 
CREB phosphorylation data, nuclear accumulation of native PKAcat was significantly inhibited in 
the presence of endocytic blockade (Figures 2.4d&e).  
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Despite a clear increase in PKAcat present in the nuclear fraction, we were unable to detect a 
corresponding loss in the cytoplasmic fraction in response to endogenous Β2AR activation 
(Figures 2.4c&e, gray lines). This suggests that nuclei contain only a very small fraction of total 
cellular PKAcat, enabling nuclear accumulation to occur without detectable depletion of the much 
larger cytoplasmic pool. We verified this by comparing amounts of PKAcat recovered in isolated 
nuclei to those in the starting whole cell lysate, normalizing each amount to HDAC2 to assure equal 
nuclear representation in each fraction. This analysis verified that, indeed, the amount of native 
PKAcat present in nuclei is small relative to the amount present in the whole cell lysate under all 
conditions (Figures 2.4f&g). Overall, we estimated the nuclear fraction of PKAcat to be on the order 
of 1-2% of the total amount present in the cell.  
 
Similar results were obtained in gene-edited cells (HEK293T mNG2-PKAcat), in which it was 
possible to estimate relative protein concentrations by mNG2 fluorescence intensity imaged by 
confocal microscopy through a mid-section of the cell. mNG2-PKAcat fluorescence was much 
lower in the nucleus than in the cytoplasm, and a particularly large difference in apparent 
concentration was evident between the nucleus and perinuclear pool (Figure 2.5a).  
 
We next asked if it is possible to detect regulated nuclear accumulation of endogenously labeled 
PKAcat by live imaging. Nuclear accumulation of labeled PKAcat was easily observed in gene-
edited cells after application of forskolin combined with IBMX (Figure S2.3a), consistent with 
previous results showing native PKAcat accumulation in nuclei after supra-physiologic cAMP 
cascade activation (Nigg et al., 2000). However, we were initially unable to detect nuclear 
accumulation in response to activation of endogenous Β2AR-Gs using isoproterenol (Figure 2.5b, 
top row). Based on the biochemical results indicating that only a very small amount of PKAcat 
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accumulates in the nucleus in response to endogenous Β2AR-Gs activation, we reasoned that it 
might be difficult to detect such accumulation to be visible by microscopy due to the inherent 
signal-to-noise limitations of live cell imaging. We also considered the possibility that the added 
molecular mass contributed by mNG2 (~25 kDa) in the cytoplasm might reduce the ability of 
labeled PKAcat to enter the nucleus. 
 
To address these potential limitations, we sought to increase the sensitivity of our live imaging 
assay and decrease the mass of the endogenously labeled PKAcat during nuclear entry. We 
addressed both by taking advantage of the fact that the genome-edited version of PKAcat 
possesses only the last beta-strand of mNG2 (PKAcat11), encoding a non-fluorescent polypeptide 
adding only a small amount (~2 kDa) of molecular mass to PKAcat relative to the native protein, 
and then the fluorescent species is formed in a second step by assembly with mNG21-10 in the 
cytoplasm. As split mNG2 protein complementation is a time-dependent process, we reasoned 
that some fraction of non-complexed PKAcat11 likely exists in the cytoplasm at steady state, and 
that this might be ‘trapped’ after nuclear entry by complex formation with a nucleus-localized 
version of mNG21-10 (NLS-mNG21-10; Figure 2.5c). This strategy appeared to be successful 
because isoproterenol application produced a visible increase in nuclear mNG2 fluorescence in 
cells co-expressing NLS-mNG21-10 (Figure 2.5b, bottom row). 
 
We verified this effect by blinded quantification of fixed specimens using an IRES-linked blue 
fluorescent protein marker to identify those cells transiently co-expressing NLS-mNG21-10 (Figure 
2.5d). When nuclear fluorescence was measured in live image series, isoproterenol produced an 
increase in nuclear mNG2-PKAcat fluorescence that was clearly detectable above experimental 
background and exhibited a time-dependence similar to the nuclear accumulation of native PKAcat 
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detected biochemically (Figures 2.5e&f). Moreover, endocytic blockade inhibited the isoproterenol-
induced nuclear accumulation of endogenously labeled PKAcat (Figures 2.5g&h). Taken together, 
these observations independently verify that endogenous Β2AR-Gs activation indeed drives 
PKAcat accumulation in the nucleus, and that this process requires endocytosis. 
 
A diffusible pool of PKAcat during the plateau phase of the cAMP response 
After identifying PKAcat nuclear accumulation as a key endocytosis-dependent step in the 
integrated signaling pathway, we next asked how this is possible. Unleashed PKAcat enters the 
nucleus by diffusion through nuclear pores (Harootunian et al., 1993), inherently requiring the 
presence of a diffusible pool of PKAcat outside of the pore to drive net entry of PKAcat by mass 
action. However, our imaging data indicate that PKAcat is non-uniformly localized in the cytoplasm 
during the plateau signaling phase and exhibits a pronounced perinuclear accumulation similar to 
that in unstimulated cells. In unstimulated cells, such localization reflects PKAcat being stably 
bound in inactive holoenzyme complexes that cannot enter the nucleus due to their large size and 
anchoring to cytoplasmic structures through binding to AKAPs. Accordingly, it was not clear from 
our imaging data if there even exists a diffusible pool of PKAcat in the cytoplasm that could 
possibly support nuclear entry of PKAcat during the time that such entry is detected. 
 
This apparent paradox forced us to reconsider our interpretation of cytoplasmic PKAcat 
localization at steady state. While a non-uniform protein distribution inherently implies some degree 
of protein immobilization, it does not necessarily rule out the existence of a diffusible pool. To test 
this possibility in a more sensitive way, we carried out fluorescent recovery after photobleaching 
(FRAP) analysis and used recovery of fluorescent protein in the photobleached volume to detect 
the presence of a diffusible pool. In unstimulated cells, little recovery of PKAcat fluorescence 
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occurred over a 5 minute imaging period after photobleaching (Figure 2.6a, top row; boxes 
indicate the photobleached area), verifying that the vast majority of PKAcat is indeed immobilized 
under this condition (Figures 2.6a & S2.4a). However, after prolonged isoproterenol exposure 
driving cells into the plateau phase of cAMP signaling, fluorescence recovery in the localized 
perinuclear pool was substantially increased (Figure 2.6a, bottom row). Quantification across 
multiple experiments verified this result, indicating that ~50% of endogenously labeled PKAcat is 
exchangeable during the plateau phase of the integrated response (Figures 2.6a & S2.4a). Thus 
there does indeed exist a substantial diffusible pool of PKAcat in the cytoplasm during the plateau 
phase of the endogenous cAMP response during which PKA accumulation occurs. Interestingly, 
endocytic blockade did not detectably affect the FRAP recovery curve (Figure 2.6b). These results 
suggest that the presence of diffusible PKAcat represents a changed global property of the 
cytoplasm that is characteristic of the plateau signaling phase, likely due to the moderate elevation 
of global cAMP concentration, which is not itself endocytosis-dependent. 
 
Nuclear entry of PKAcat is sufficient to explain the transcriptional response 
We next compared the time course of endocytosis-dependent nuclear PKAcat entry to 
downstream events in the integrated transduction pathway. The ultimate transcriptional response 
clearly lagged nuclear PKAcat accumulation, first becoming detectable after agonist exposure for 
30-45 minutes (Figure 2.7a&b) despite the endocytosis-dependent component of native PKAcat 
accumulation reaching a plateau within 20-30 minutes (Figure 2.7c). Further, when intermediate 
events were plotted on the same time scale, a clear temporal order was evident (Figures 2.7c-e). 
Accordingly, downstream steps in the pathway follow nuclear accumulation of PKAcat, both in 
their kinetics and dependence on endocytosis. These results indicate that nuclear entry of PKAcat 
is the critical step in the integrated transduction cascade at which the dependence on endogenous 
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Β2AR-Gs activation in endosomes is introduced, and suggest that this step is sufficient to explain 
the location-aware nature of downstream transcriptional control.  
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2.4 Discussion 
The present study addressed the question of how GPCR-Gs activation in endosomes is coupled 
downstream to a cAMP-dependent transcriptional response. We focused on the Β2AR as an 
interesting example because the transcriptional response elicited by this GPCR, when studied at its 
endogenous expression level, is endocytosis-dependent even though Β2AR-Gs activation from 
endosomes does not produce a large increase in the overall amount or duration of cytoplasmic 
cAMP elevation. This provides additional support for the conclusion that transcriptional signaling 
elicited by endogenous Β2AR-Gs activation is determined primarily by the subcellular location of 
upstream cascade activation, rather than by its overall amount or timing. We investigated the 
cellular basis of such ‘location-aware’ downstream signaling, and resolved the overall cAMP 
response elicited by endogenous Β2AR-Gs activation into two phases. A peak phase is 
characterized by a large but transient increase in the overall concentration of cAMP, and this is 
followed by a plateau phase of more moderate cAMP elevation which persists in the continued 
presence of agonist but is still agonist-dependent (Figures 2.8a&b). PKAcat rapidly disperses 
throughout the cytoplasm during the peak phase of the overall cAMP response and re-
accumulates in the perinuclear pool during the plateau phase, effectively mirroring the overall cAMP 
response (Figure 2.8c). Interestingly, neither of these behaviors requires endocytosis, and the 
endocytosis-dependent nature of the downstream transductional response is introduced instead 
one step downstream – at the stage of nuclear accumulation of PKAcat – with subsequent steps in 
the pathway following both in their kinetics and sensitivity to endocytic inhibition. Taken together, 
these results support a model of endosomal signaling via the cAMP cascade that uses the 
subcellular location of activation as a primary cue, and conveys location-aware information 
downstream by nuclear accumulation of PKAcat. 
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Previous studies indicate that polypeptide hormone receptors use endocytosis to produce a high 
level of cAMP accumulation in the cytoplasm which is sustained after agonist removal. We show 
here that the Β2AR produces high-level cAMP accumulation transiently, defining the peak phase of 
the response, and that this phase is only moderately prolonged by endocytosis. The transient peak 
is followed by a markedly reduced (~10-fold) degree of cAMP elevation, defining the plateau phase, 
which is only slightly enhanced by endocytosis and remains ligand-dependent because it is rapidly 
reversed by antagonist. Previous studies have identified a cellular mechanism for transducing the 
nuclear effects of sustained and high-level cAMP elevation, based on the activation of a discrete 
pool of PKA holoenzyme that is restricted to the nucleus and is relatively insensitive to cAMP based 
on scaffolding with PDE4 (Clister et al., 2019). This mechanism is unlikely to transduce the 
transcriptional response elicited by endosomal Β2AR-Gs activation because cytoplasmic cAMP 
reaches a high concentration only transiently. Thus we believe that the downstream transduction of 
endosomal Β2AR-Gs activation relies on a different cellular mechanism, based instead on nuclear 
accumulation of PKAcat from the cytoplasm. 
 
We anticipate that these different cellular mechanisms for achieving downstream signaling 
selectivity to the nucleus can operate together in the same cells, and are deployed to different 
degrees depending on the particular receptor activated. Considering that polypeptide hormone 
receptors and Β2ARs have been shown to be able to transit the same endosomes after ligand-
induced internalization, it is also possible that these mechanisms operate together in the same 
compartment and contribute to synergistic effects across GPCRs. We also note that endocytosis 
inherently changes the location of upstream cascade activation irrespective of the particular GPCR 
internalized, and that unleashing of PKAcat from the perinuclear cytoplasmic pool was shown 
previously to contribute to cAMP-dependent signal transduction to the nucleus elicited by 
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polypeptide hormone receptors. Conversely, the present results indicate that endocytosis 
produces a moderate increase in the duration of the peak phase of high-level cAMP accumulation 
elicited by the Β2AR, albeit not to the extent of producing a sustained and high-level cAMP 
accumulation response as is the case for polypeptide hormone receptors. Accordingly, these 
fundamentally different cellular mechanisms of endosomal signal specification may operate 
together even for an individual GPCR. If so, this could enable cells to further enhance the specificity 
of signaling downstream of endosomal GPCR-Gs activation.  
These results provide significant insight into the cellular basis of location-aware cAMP 
signaling from endosomes, but they also raise additional questions about its underlying 
biochemical basis that remain to be investigated. For example, it is presently unknown which 
adenylyl cyclase isoform(s) mediate location-aware signaling from endosomes. Mammals express 
nine transmembrane adenylyl cyclase (AC) isoforms that are directly activated by Gs, with two 
presently implicated in sustained cAMP signaling from endosomes elicited by polypeptide hormone 
receptors (Sunahara & Taussig, 2002). Mammals also express another AC isoform (AC10 or sAC) 
that lacks any transmembrane domains and is not directly activated by Gs, yet is also implicated in 
signaling from endosomes (Inda et al., 2016). It is not known if the same AC isoforms that mediate 
sustained endosomal responses also mediate transient cAMP elevation followed by a ligand-
dependent plateau phase, which is characteristic of location-aware signaling by the Β2AR. We also 
do not know if there exist other proteins, besides the core cascade components studied here, 
needed at the endosome membrane to confer signaling specificity to the nucleus. For example, 
signaling specificity downstream of GPCR-Gs activation at the plasma membrane critically 
depends on scaffolding by A-kinase anchoring proteins (AKAPs), and AKAPs are known that 
localize to endosomes (Søberg & Skålhegg, 2018; Taylor et al., 2012). What function(s) such 
scaffold proteins have in determining signaling specificity from endosomes, and what other 
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scaffold-associated proteins might also contribute, are additional questions raised by the present 
results that merit future investigation.  
 
The ability of the cAMP cascade to mediate location-aware signaling from endosomes also raises 
interesting biophysical questions, particularly with regard to the diffusible nature of cAMP and 
PKAcat. At presently estimated rates of free diffusion, both cAMP and PKAcat would be expected 
to equilibrate throughout the cytoplasm within several seconds or less. This is advantageous for 
endosomal responses that are conveyed to the nucleus by a sustained elevation of overall 
cytoplasmic cAMP concentration, but is problematic for location-aware responses conveyed by 
nuclear accumulation of PKAcat. Whereas cAMP generated from endosomes is already known to 
locally activate PKA in the perinuclear region through enforced proximity and membrane tethering, 
locally unleashed PKAcat must then accumulate in the nucleus. Based on previous studies 
indicating that PKAcat enters the nucleus by diffusion and is then actively exported (Harootunian et 
al., 1993; Wen et al., 1995), we assume that endocytosis-dependent nuclear accumulation of 
PKAcat reflects an increase in unleashed PKAcat entry; this would require an increased free 
concentration at the outer nuclear membrane to drive nuclear entry by mass action. Endosomes in 
which Β2AR-Gs activation has been shown are readily resolved from the nucleus using diffraction-
limited confocal microscopy, indicating that they are at least 200 nm away. However, local 
concentration gradients around sites of diffusible mediator production typically dissipate within a 
distance scale of tens of nanometers. These considerations reveal a distance ‘gap’ that we 
presently cannot explain, as we do presently do not detect an obvious effect of endocytosis on 
PKAcat localization or dynamics in the perinuclear region.  
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One possible explanation is that we are missing a population of endosomes that are located closer 
to the nucleus than we are presently able to resolve, and are the actual sites of location-aware 
signaling to the nucleus. Another possibility is that we are missing an additional endocytosis-
dependent protein (such as a regulator of nuclear import or export) that conveys a longer-range 
effect on nuclear PKAcat. A third possibility is suggested by the present FRAP data, revealing a 
rate of PKAcat fluorescence recovery 10-100 fold slower than expected from free diffusion. In 
principle, this could reflect slow equilibration of a rapidly diffusing protein pool due to limited 
availability of binding sites, or it could reflect slowed effective diffusion due to rapid binding of 
PKAcat and ‘hopping’ from one site to another. We suggest that the latter behavior is possible 
because PKA regulatory subunits are present at high concentration in the cytoplasm and in 
substantial excess to PKAcat that they bind, and because the rate of PKAcat:PKAreg association 
approaches the diffusion limit in vitro. If slow FRAP kinetics indeed reflect an effective diffusion 
regime during the plateau signaling phase, this by itself could significantly increase the distance 
scale over which local unleashing of PKAcat is propagated in the plateau phase. Future studies, 
using additional biochemical and biophysical approaches, will be required to test this hypothesis, 
and to further elucidate other aspects of the discrete cellular mechanism of location-aware 
signaling to the nucleus that the present results delineate. 
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2.6 Materials and methods 
Cell culture  
Human HEK293 and HEK293T cells were grown in DMEM (Gibco, 11965) supplemented with 10% 
fetal bovine serum (UCSF Cell Culture Facility). Cells were grown at 37°C and 5% CO2 in a 
humidified incubator. HEK293 stable cell lines, FLAG-β2AR (Cao et al., 1999) and GloSensor20F-
IRES-Rluc, were generated from the parent cell line by transfection of the plasmid of interest 
followed by antibiotic selection.  
 
DNA transfections 
Cells were seeded at 70% confluency in a well of a 6 well plate (Corning) or a 35 mm imaging dish 
(MatTek, P35G-1.5-14-C) and transfected overnight with 4 μL Lipofectamine 2000 (Invitrogen). 
Media was changed the next day and cells were used within 24-48 hours post transfection for 
experimentation. 
Table 2.1 Amounts of transfected DNA constructs 
 
Plasmid Amount (ng) 
pcDNA3 300 
pcDNA3 mCherry-Dyn1 300 
pcDNA3 mCherry-Dyn1-K44E 300 
pcDNA3.1+ 2x NLS mNG21-10 IRES TagBFP 400 
pcDNA3.1+ SSF-Β2AR 1000 
 
siRNA transfections 
Cells were seeded at 30% confluency in a 10 cm dish and transfected overnight with 200 pmol 
siRNA (Qiagen) with 24 μL RNAiMax Lipofectamine (Invitrogen). Media was changed the next day 
and cells recovered for another 48 hours before experimentation. If DNA transfection was 
performed, cells were transfected with DNA and Lipofectamine 2000 (Invitrogen) 24 hours before 
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experimentation. The siRNAs used were All Star Negative (Control; Qiagen, SI03650318) and 
CHC17 siRNA (Qiagen, 5'-AAGCAATGAGCTGTTTGAAGA-3'). 
 
Endocytic blockade by Dyngo-4A 
Cells treated with Dyngo-4A were first changed to serum free media. Then DMSO (control) or 30 
μM Dyngo-4A was added to cells for 15 minutes to block endocytosis prior to the experiment. 
 
DNA constructs 
cAMP luminescence biosensor with renilla luciferase  
pSF CMV GloSensor20F IRES Rluc was made from pSF CMV EMCV Rluc (Boca Scientific) and 
pGloSensor-20F (Promega). GloSensor20F DNA was PCR amplified, and 5’ EcoRI and 3’ EcoRV 
sites were added. The vector, pSF CMV EMCV Rluc, was digested with EcoRI and EcoRV and an 
InFusion (Clontech) reaction was used to insert GloSensor20F into the vector. 
 
Nuclear localized mNG21-10 
pcDNA3.1+ 2xNLS mNG21-10 IRES TagBFP was made by a multiple insert ligation with QuickLigase 
(NEB) put all inserts into pcDNA3.1+ (Clontech). A gBlock (IDT) of 2x NLS (SV40) mNG21-10 was 
ordered and PCR amplified with 5’ BamHI and 3’ XhoI AgeI NotI. An IRES fragment was PCR 
amplified from pSF CMV EMCV Rluc (Boca Scientific) with 5’ AgeI and 3’ XhoI. Lastly, TagBFP was 
amplified with 5’ XhoI and 3’ XbaI.  
 
cAMP fluorescence biosensor 
The cAMP fluorescence biosensor was generated from a human Epac2 cAMP FRET sensor with 
the cpGFP from Green GECO 1.0 (Zhao et al., 2011). H4 and H6 helix-containing fragments of the 
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Epac2-derived cAMP-binding module were inserted in place of the M13 peptide and EF hand-
containing calcium binding modules in GCaMP6f, respectively, using a variable linker strategy in E. 
coli.  
 
cAMP fluorescent biosensor development 
Primary screening was carried out by assay of isoproterenol-dependent fluorescence changes in 
HEK293 cells transiently transfected with plasmid DNA minipreps using Lipofectamine 2000 
(Invitrogen) per the manufacturer's instructions, imaged by epifluorescence microscopy and 
selecting for an upward-deflecting fluorescence response. Primary screening was performed by 
imaging of living cells in HEK293 cells 24 hours after transfection in MatTek dishes using a custom-
built 37˚C incubation chamber fit to an inverted epifluorescence microscope (Nikon TE2000) 
equipped with a 20X NA 0.5 Plan Fluor objective and custom-built LED illuminator with 485/20x 
bandpass emission filter (Chroma). Images were collected through a 504 nm dichroic mirror and 
525/30m bandpass filter (Chroma) using a cooled CCD camera (Roper CoolSNAP HQ), with LED 
illumination and fluorescence acquisition controlled using Micromanager and ImageJ. Kinetic 
analysis was carried out on serial image stacks collected in the linear range of detection using Plot 
Profile in ImageJ. 
 
HEK293T mNG2-PKAcat cells 
Cells were obtained from the Huang lab at UCSF. Briefly, HEK293T cells expressing mNG21-10 were 
electroporated with Cas9/sgRNA RNP complexes and the HDR template for the PKAcat gene, 
PRKACA. Electroporated cells were cultured for 5-10 days before FACS selection for 488-GFP 
positive cells. Next, genomic DNA was extracted from the knock-in cell line and the genomic DNA 
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was amplified with three primer sets around the knock-in site. The amplified products were sent for 
sequencing to verify knock-in of mNG211 at the N-terminus of PKAcat.   
 
RNA extraction 
RNA was isolated from cells using the QIAshredder and RNeasy Mini kit (Qiagen, 79654 and 
74104, respectively). Briefly, after treatment, cells in a 6 well plate were placed on ice and washed 
once with cold PBS. Then cells were lysed, and RNA was extracted by following the 
manufacturer’s protocol. RNA was eluted in 30-50 μL of DEPC H2O, and the concentration of each 
sample was determined. 
 
Reverse transcription reaction 
cDNA was generated from RNA using the SuperScript III First-strand synthesis system (Invitrogen, 
18080-051). Briefly, 2 μg of RNA was used per reaction primed with oligo dT. The reverse 
transcription reaction was performed according to the manufacturer’s protocol.   
 
qRT-PCR 
qRT-PCR was performed using a StepOnePlus (Applied Biosystems) instrument. cDNA generated 
from extracted RNA was used as the input for the qRT-PCR, with amplification by Power SYBR 
Green PCR master mix (Applied Biosystems, 4367659). Levels of transcripts were normalized to 
GAPDH. The primer pairs used is in Table 2.2. 
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Table 2.2 qRT-PCR primer sequences 
 
Primer Sequence 
GAPDH forward 5’-CTGCCCAAGATCTTCCATGT-3’ 
GAPDH reverse 5’-GACAAGCTTCCCGTTCTCAG-3’ 
PCK1 forward 5’-CTGCCCAAGATCTTCCATGT-3’ 
PCK1 reverse 5’-CAGCACCCTGGAGTTCTCTC-3’ 
CHC17 forward 5’-ACTTAGCCGGTGCTGAAGAA-3’ 
CHC17 reverse 5’-AACCGACGGATAGTGTCTGG-3’ 
 
cAMP luminescence assay 
HEK293 cells stably expressing a cAMP luciferase-based biosensor (GloSensor20F-IRES-Rluc) 
were lifted and resuspended in imaging media (DMEM without phenol red (Gibco, 31053) 
supplemented with 30 mM HEPES). These cells were then incubated with 1.6 mM D-luciferin (Gold 
Biotechnology, LUCNA-1g) for one hour at 37°C and 5% CO2 in a humidified incubator and 
distributed into a 24 well plate (200 μL/well). Immediately before imaging, cells were treated with 
200 μL imaging media only (DMEM without phenol red supplemented with 30 mM HEPES; Gibco 
31053 and 15630 respectively) or imaging media with isoproterenol (100 nM final; Sigma, I6504) 
and placed into a 37°C heated light-proof chamber, then imaged every 10 seconds for 20 minutes. 
When the cAMP luminescence image series finished, 100 μL of 5x stop buffer (to eliminate firefly 
luciferase luminescence) with 10 μM coelenterazine (Gold Biotechnology, CZ2.5) was added to 
each well. Renilla luciferase luminescence was immediately imaged at 10 second intervals for one 
minute. 
 
Images were acquired by a 512 × 512 pixel electron multiplying CCD sensor (Hamamatsu C9100-
13) using Micro-Manager. Using Fiji, ROIs were drawn around each well, and corresponding 
background ROIs were placed in an area without cells. Intensity over time was measured and 
corrected for background luminescence for both firefly and renilla luciferase values. The renilla 
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luminescence values over the time series was averaged (renillaavg). A ratio (if/r) of firefly to renillaavg 
luminescence was calculated per well over time. Next, each time series was initialized to the 
average of the first 5 time points (inew = if/r - i5avg). The max (average of the top 5 proximal values) of 
each isoproterenol treated condition was determined, and each condition was normalized to the 
max of the control isoproterenol treated sample. 
 
Spinning disk confocal imaging 
Imaging was performed on a Nikon Ti inverted spinning disk confocal microscope (Yokogawa 
CSU-W1) with 405-, 488-, 561- and 640-solid-state lasers (Andor) and an Andor Zyla 4.2 sCMOS 
camera controlled by μManager (2.1 beta) software. Cells were kept in imaging media (DMEM 
without phenol red supplemented with 30 mM HEPES) and were maintained in a temperature- and 
humidity-controlled chamber (Okolab) during imaging. 
 
cAMP fluorescence imaging assay 
Images were acquired with the spinning disk confocal microscope previously described using a 
Plan Apo λ 20x 0.75 NA objective (Nikon). Cells were imaged every 20 seconds for 45 minutes at 
37°C. Cells were treated with 100 nM isoproterenol (Iso) at 5 minutes, 10 μM alprenolol (Alp) at 35 
minutes, and 10 μM FSK and 500 μM isobutylmethylxanthine (IBMX) at 40 minutes. 
 
ROIs were drawn around the entire cell, with corresponding ROIs of the same size were placed in 
an area nearby without cells to determine the background signal. Each cell fluorescence intensity 
was background subtracted. Next, the reference fluorescence was set to be the fluorescence at 5 
minutes right as 100 nM isoproterenol was to be added. The change in fluorescence over the 
reference fluorescence was then determined for all time points. 
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Perinuclear PKAcat redistribution assay 
Images were acquired with the spinning disk confocal microscope previously described using a 
Plan Apo VC 60x 1.4 NA objective (Nikon). Cells were imaged every 5 minutes for 35 minutes, 
except for additional time points at 30 seconds and one minute. Cells were treated with imaging 
media only (untreated) or 100 nM Iso in imaging media immediately after the initial image (~t=5s). 
 
ROIs were drawn around perinuclear PKAcat with corresponding ROIs of the same size placed in a 
nearby area without cells to determine the background signal. The perinuclear fluorescence 
intensity was background subtracted. Each time point was normalized to the initial intensity for 
each condition. 
 
Fixed imaging of nuclear PKAcat 
HEK293T mNG2-PKAcat cells were either Untransfected or transfected with 2x NLS mNG21-10 IRES 
TagBFP were plated on poly-L-lysine (Sigma, P8920) coated coverslips (Fisher, 12-545-100) in 12 
well plates. Cells untreated or treated with 100 nM isoproterenol for 45 minutes at 37°C. Cells were 
then washed 3 times with PBS and fixed with 3.7% formaldehyde (Fisher, F79) in PBS for 20 
minutes. Cells were washed again with PBS followed by a TBS wash. Cells were stained with 1 μM 
DRAQ5 (Invitrogen, 62251) in PBS for 5 minutes. Cells were washed with PBS and mounted on 
glass slides with ProLong Gold Antifade mounting media (Invitrogen, P10144). Slides were stored 
for a minimum of 24 hours to allow mounting media to dry before imaging. Cells were imaged on 
the previously described spinning disk confocal microscope using a Plan Apo VC 60x 1.4 NA 
objective (Nikon).  
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First, the 647 nm channel was selected to draw ROIs in nuclei of all cells in the field of view. Next, 
for cells transfected with 2x NLS mNG21-10 IRES TagBFP, ROIs were retained for cells positive in the 
405 nm channel. Then, for cells transfected with mCherry-Dyn1-K44E, ROIs were retained for cells 
positive in the 561 nm channel. Lastly, ROIs were checked that they only contained the nucleus of 
mNG2-PKAcat expressing cells by checking the 488 nm channel. Corresponding background 
ROIs were taken in an area without any cells, and the intensity of the nuclear ROI was background 
subtracted. Intensities of each condition were averaged, and the 45 minute treated samples were 
normalized to the corresponding untreated samples. 
 
Nuclear PKAcat accumulation live imaging assay 
HEK293T mNG2-PKAcat cells transfected with 2x NLS mNG21-10 IRES TagBFP were imaged with 
the spinning disk confocal microscope previously described using a Plan Apo VC 60x 1.4 NA 
objective (Nikon). Cells were initially imaged at 0, 0.5, 1 and 5 minutes, then were imaged every 5 
minutes for 45 minutes at 37°C. Cells were treated with 100 nM isoproterenol (Iso) immediately 
after the time lapse started (within ~5 s). 
 
Transfected cells were first identified by checking the 647 nm channel. ROIs marking transfected 
cells were first draw then adjusted to mark the nucleus of each transfected cell. Corresponding 
background ROIs were not used as background intensity was not always less than the intensity 
from the nuclear ROI. The change in fluorescence over the initial fluorescence was then determined 
for all time points. 
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Fluorescence recovery after photobleaching of perinuclear PKAcat 
Images were acquired with the spinning disk confocal microscope previously described using a 
Plan Apo VC 100x 1.4 NA objective (Nikon). A Rapp Optoelectronic UGA-40 photobleaching 
system was used to photobleach mNG2-PKAcatα in an ROI primarily containing the Golgi with a 
473 nm laser (Vortran). Cells were imaged at 10 second intervals for 5.5 minutes (except for an 
added interval of 5 seconds before photobleaching) and photobleached at 30 seconds to monitor 
fluorescence recovery after photobleaching.  
 
Quantitative image analysis was performed on unprocessed images using Fiji software by drawing 
ROIs around the bleach spot and taking the fluorescence intensity from each frame. 
Corresponding ROIs in areas without cells were used for background subtraction. Intensity frame 
immediately following photobleaching was set to zero, then the intensity at each time point was 
normalized to the initial intensity. 
 
CREB phosphorylation 
After treatment with isoproterenol, cells in a 6 well plate were lysed on ice with 200 μL/well RIPA 
buffer (50 mM Tris, 150 mM NaCl, 1% Triton X-100, 0.5% Sodium Deoxycholate, 0.1% Sodium 
Dodecyl Sulfate) containing Complete Mini, EDTA-free (Roche, 11836170001) and PhosSTOP 
(Roche, 04906837001) for 25 minutes. Lysates were then transferred to microcentrifuge tubes and 
spun for 10 minutes at 14,000 rpm at 4°C. The supernatant was then saved and used for 
immunoblot experiments. Protein concentration was determined by BCA Protein Assay (Thermo 
Fisher, 23225). 
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Protein samples were mixed with NuPage LDS Sample Buffer (Invitrogen, NP0007) and 1 mM 
dithiothreitol (DTT) (Sigma, D0632). Samples were loaded into a NuPAGE 4-12% Bis-Tris Protein 
gel (Invitrogen, NP0335BOX) and transferred to nitrocellulose prior to immunoblot analysis. 
 
Nuclear cytoplasmic separation 
Nuclear-cytoplasmic separation was performed using the NE-PER Nuclear and Cytoplasmic 
Extraction Reagents (Thermo Scientific, 78833) and according to the manufacturer’s protocol. 
Briefly, after treatment with isoproterenol, cells were washed with PBS then lifted with TrypLE 
Select (Gibco, 12563) from a 6 cm dish. Cells were transferred to a microcentrifuge tube and spun 
down at 500 g for 5 minutes. The cell pellet was washed with PBS and spun again at 500 g for 3 
minutes. Then cell pellets were placed on ice and resuspended with 200 μL CER I, vortexed and 
placed back on ice for 10 minutes. Next, 11 μL of CER II was added to each tube and vortexed 
briefly and put on ice for 1 minute. The tubes were then spun at 20,000 g for 5 minutes. The 
supernatant was removed and saved as the cytoplasmic fraction. To obtain the nuclear fraction, 
100 μL NER was added to the pellet and the pellet was vortexed briefly 5 times with 10 minute 
incubations on ice in between. Then the samples were spun down at 20,000 g for 10 minutes, and 
the supernatant was saved as the nuclear fraction. 
 
Protein samples were mixed with NuPage LDS Sample Buffer (Invitrogen, NP0007) and 1 mM 
dithiothreitol (DTT) (Sigma, D0632). Samples were loaded into a NuPAGE 4-12% Bis-Tris Protein 
gel (Invitrogen, NP0336BOX) and transferred to nitrocellulose prior to immunoblot analysis. 
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Immunoblot analysis 
After transfer onto nitrocellulose, membranes were stained with Ponceau S solution (Sigma, 
P7170-1L) to check for transfer quality. Membranes were washed with PBS to remove the 
Ponceau S solution before blocking with Odyssey blocking buffer. For blots where phosphorylated 
CREB was to be detected, Odyssey TBS blocking buffer (LI-COR Biosciences, 927-50000) was 
used, otherwise all other blots used Odyssey PBS blocking buffer (LI-COR Biosciences, 927-
40000). The following primary antibodies were used to probe for proteins with interested with the 
corresponding secondary antibodies. The blots were imaged on an Odyssey Infrared Imaging 
System (LI-COR Biosciences) and bands were analyzed by ROI analysis with background 
subtraction in Fiji.  
 
Table 2.3 Antibodies used for immunoblot detection of proteins 
 
Antibody Manufacturer Catalog # 
Mouse anti CREB (86B10) Cell Signaling Technologies 9104 
Rabbit anti pCREB (S133) (87G3) Cell Signaling Technologies 9198 
Rabbit anti PKA C-α Cell Signaling Technologies 4782 
Mouse anti HDAC2 (3F3) Cell Signaling Technologies 5113 
Mouse anti α-tubulin (DM1A) Cell Signaling Technologies 3873 
IRDye 680RD Donkey anti-Mouse IgG LI-COR Biosceinces 926-68072 
IRDye 800CW Donkey anti-Rabbit IgG LI-COR Biosceinces 926-32213 
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Supplemental Materials and Methods 
Flow cytometry 
Cell surface fluorescence of HEK293 cells stably expressing FLAG-β2AR was measured to 
determine receptor endocytosis. Cells were incubated with 100 nM isoproterenol for 30 minutes at 
37°C to internalize receptors to steady state. After treatment, cells were washed with cold PBS 
three times, then incubated with 1 μg/ml AlexaFluor647-conjugated (Invitrogen, A20173) M1 
mouse anti Flag monoclonal (Sigma, F-3040) antibody at 4°C for one hour on a shaker. Cells were 
mechanically lifted and mean fluorescence was read by flow cytometry for each sample on a 
FACSCalibur (BD). Each condition had three technical replicates per biological replicate.  
 
cAMP fluorescence sensor secondary screen 
Secondary screening and cAMP concentration-response determination were carried out in vitro 
using a cytoplasmic fraction prepared from transiently transfected HEK293 cells by Dounce 
homogenization in 100 mM KCl 30 mM HEPES pH7.4 and PMSF followed by centrifugation at 
40,000 g for 10 minutes. The supernatant was maintained on ice, adjusted to 1 mg/mL total 
protein concentration and then supplemented with 100 μM isobutylmethylxanthine (IBMX; Sigma, 
I5879) before assays.  Fluorescence was monitored using 100 μL aliquots in a 96-well plate, at 
room temperature and in the presence of added cAMP as indicated, using a Gemini XPS 
fluorimeter (Molecular Dynamics) set to 488 nm excitation and 510 nm emission.  Mean values 
derived from duplicate fluorescence determinations were analyzed according to a single-site 
binding model (F / Fo = max * [cAMP] / {[cAMP] + KD}) fit by a non-linear regression method 
(sigmoidal, 4PL, least squares fit) using Prism (GraphPad).  
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HEK293T immunoblot for PKAcat 
The parent cell line, HEK293T mNG21-10 and the knock-in cell line, HEK293T mNG2-PKAcat were 
both lysed with RIPA buffer containing Complete Mini, EDTA-free protease inhibitor. Cells were 
collected in microcentrifuge tubes and spun down at 14,000 rpm for 10 minutes at 4°C. The 
supernatant was removed and saved for immunoblot analysis. Protein concentrations were 
determined by BCA protein assay. 
 
Detection of nuclear PKAcat in HEK293T mNG2-PKAcat cells by live imaging 
HEK293T mNG2-PKAcat cells were imaged either untreated or treated with 10 μM FSK and 100 
μM IBMX for 60 minutes. Images at 0 minutes and 60 minutes were acquired on a Nikon Ti 
inverted spinning disk confocal microscope (Yokogawa CSU-22) with a custom 405-, 488-, 561- 
and 640-laser launch, with an Apo TIRF 100x/1.49 NA Oil objective (Nikon) and a Photometrics 
Evolve Delta EMCCD camera controlled by Nikon Elements software. Cells were kept in a 
temperature- and humidity-controlled chamber (Okolab) during imaging. 
 
Photobleaching recovery non-linear curve fit 
Photobleaching data was replotted to set the time of bleaching at 0 seconds. Non-linear 
regression (sigmoidal, 4PL) was then performed on each condition using Prism (GraphPad) to 
determine half-time and plateau values. 
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2.8 Figures 
  
 
Figure 2.1 Magnitude and kinetics of cAMP signaling 
Amount. a. Endocytic blockade by dominant negative dynamin (Dyn1-K44E) reduces β2AR-stimulated cAMP. HEK293 
cells expressing a cAMP luciferase biosensor was coexpressed with either pcDNA3 (control) or mCherry-Dyn1-K44E. 
Cells were untreated or treated with 100 nM Iso. The maximum luminescence value (using a window averaging 5 
proximal values) of each sample was determined and normalized to the control iso condition. (n = 3, P = 0.0038, two-
tailed unpaired t-test.) b. Endocytic blockade by dominant negative dynamin (Dyn1-K44E) reduces β2AR-stimulated 
induction of PCK1. qRT-PCR was performed on samples from HEK293 cells transfected with pcDNA3 (control) or 
mCherry-Dyn1-K44E followed by two hours of 100 nM Iso. (n = 5, P < 0.0001, two-tailed unpaired t-test.) c. Production 
of cAMP increases with concentration of Iso. HEK293 cells expressing a cAMP luciferase biosensor were untreated or 
treated with 100 nM Iso, 10 nM Iso and 1 nM Iso. The maximum luminescence value (using a window averaging 5 
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proximal values) of each sample was determined and normalized to the 100 nM iso condition. (n = 3, 100 nM vs 10 nM 
Iso P = 0.0003, 100 nM vs 1 nM Iso P < 0.0001, Untreated vs 1 nM Iso P = 0.6885; ordinary one-way ANOVA Sidak’s 
multiple comparisons test.) d. Induction of PCK1 increases with concentration of Iso. qRT-PCR was performed HEK293 
cells untreated and treated with 100 nM, 10 nM, and 1 nM Iso for two hours (n = 3, 100 nM vs 10 nM Iso P = 0.0969, 
100 nM vs 1 nM Iso P = 0.0004, Untreated vs 1 nM Iso P = 0.1798; ordinary one-way ANOVA Sidak’s multiple 
comparisons test.) e. Endocytic inhibition results in a smaller reduction in overall cAMP than PCK1 induction. Different 
endocytic inhibition methods (mutant dynamin1, siRNA depletion of clathrin, pharmacological inhibitor of dynamin) have a 
greater degree of reduction in PCK1 induction than in overall cAMP when compared to the control 100 nM Iso condition. 
Isoproterenol treated cells (10 nM, 1 nM doses) have a greater degree of reduction in overall cAMP than in PCK1 
induction when compared to the 100 nM Iso condition. Timing. f. Kinetics of cAMP production over time. HEK293 cells 
transiently co-expressing a cpGFP cAMP sensor and pcDNA3 (control) or mCherry-Dyn1-K44E were imaged and treated 
with 100 nM Iso for 30 minutes followed by 5 minutes of 10 μM Alp and 5 minutes of 500 μM IBMX with 10 μM FSK 
(Control, n = 4, Dyn1-K44E n = 3, P < 0.0001 for Time and Transfection, two-way ANOVA.) All data are mean ± sem. 
  
 
 
 73 
  
 
Figure 2.2 Perinuclear PKAcat initially redistributes in the cell after Iso stimulation followed by reconcentration 
a. Cartoon of split mNG21-10:mNG211-PKAcat CRISPR knock-in strategy. b-c. Representative live cell spinning disk 
confocal images of endogenously tagged mNG2-PKAcat HEK293T cells. Cells transiently expressing pcDNA3 (b, control) 
or mCherry-Dyn1-K44E (c) were untreated (top) or treated with 100 nM Iso (bottom) at 0 minutes. d. Quantification of  
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  experiments described in b and c. Examples of ROIs drawn around the perinuclear region in green. (n = 3, Control 
untreated vs Control Iso P = 0.0014, Dyn1-K44E untreated vs Dyn1-K44E Iso P = 0.0381, Control Iso vs Dyn1-K44E Iso 
P = 0.9933, Control untreated vs Dyn1-K44E untreated P = 0.8681; ordinary one-way ANOVA Sidak’s multiple 
comparisons test.) Data are mean ± sem.  
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Figure 2.3 Endocytic blockade reduces Iso-stimulated CREB phosphorylation over time 
Western blot analysis of CREB phosphorylation (Ser133) on HEK293 cells untreated and treated with 100 nM Iso for 10, 
20, 30, 45, 60, 90, and 120 minutes. Cells transiently expressing mCherry-Dyn1 (control) or mCherry-Dyn1-K44E (a), 
scramble (control) or clathrin (CHC17) siRNA (c). b and d. Quantification of Western blots in a (n = 3, Time P < 0.0001, 
Transfection P = 0.0005; two-way ANOVA) and c (n = 7, Time P < 0.0001, Transfection P = 0.0181; two-way ANOVA.) 
Data are mean ± sem.  
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Figure 2.4 β2AR endosomal signaling promotes nuclear PKAcat accumulation 
Nuclear and cytoplasmic fractions were collected from HEK293 cells untreated and treated with 100 nM Iso for 10, 20, 
30, 45 and 60 minutes. Western blot analysis of PKAcat on nuclear and cytoplasmic fractions. a. Cartoon of nuclear and 
cytoplasmic fractionation. Cells transiently expressing scramble siRNA (b, control) or clathrin siRNA (c, CHC17). d and e. 
Quantification of Western blots in b (nuclear n = 3, cytoplasmic n = 4; Time P = 0.0100 and Fraction P < 0.0001; two-
way ANOVA) and c (n = 4, ns, Time P = 0.5095 and Fraction P = 0.1782; two-way ANOVA.) f. Cartoon of nuclear fraction 
samples and whole cell lysate samples extracted from the same plate. g. Western blot quantification of PKAcat from 
whole cell lysate and nuclear samples (n = 3, P < 0.0001, two-tailed unpaired t-test.) All data are mean ± sem. 
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Figure 2.5 Endocytic blockade reduces amount of nuclear PKAcat after Iso stimulation 
a. mNG2-PKAcat mean intensities of ROIs relative to whole cell. Mean intensities from ROIs drawn around the whole cell 
(purple), nucleus (teal) and perinuclear (green) were measured and calculated as a percentage of mean ROI 
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  intensity of the whole cell (n = 3, P < 0.0001 for Cell vs Nuclear and Cell vs Perinuclear; ordinary one-way ANOVA Sidak’s 
multiple comparisons test.) b. Schematic of imaging-based assay to detect nuclear PKAcat. Cells co-expressing mNG21-
10 and endogenously-tagged mNG211-PKAcat are untransfected or transfected with nuclear (2x NLS) localized mNG21-10. 
c. Representative spinning disk confocal images of fixed cells untransfected (control, top) and transfected with nuclear 
localized mNG21-10 (bottom). Cells were untreated or stimulated with 100 nM Iso for 45 minutes. d. Quantification of fixed 
cells in c (n = 4, cells ≥ 74 per experiment; Control 0 min vs 45 min P = 0.8625, NLS 0 min vs 45 min P = 0.0003; 
ordinary one-way ANOVA.) e. Representative spinning disk confocal images of live cells expressing mNG211-PKAcat, 
mNG21-10 and nuclear localized (2x NLS) mNG21-10.) Cells were untreated (top) or treated with 100 nM Iso (bottom) at 0 
minutes. High contrast images of cells at 45 minutes on the right. f. Quantification of cells untreated or stimulated with 
100 nM Iso at 0 minutes in e (n = 3, Interaction P = 0.0012, Time and Treatment P < 0.0001, P < 0.05 untreated vs Iso 
time = 5-45 minutes, two-way ANOVA, Sidak’s multiple comparisons test.) g. Quantification of cells transiently expressing 
pcDNA3 (control) or mCherry-Dyn1-K44E (n = 4, Time and Transfection P < 0.0001, two-way ANOVA.) Data are mean ± 
sem. h. Quantification of cells transiently expressing pcDNA3 (control) or mCherry-Dyn1-K44E from g, data normalized to 
45 minute 100 nM Iso time point (n = 4, Control untreated vs Iso P < 0.0001, Dyn1-K44E untreated vs Iso P = 0.7726, 
Control Iso vs Dyn1-K44E Iso P = 0.0004; ordinary one-way ANOVA, Sidak’s multiple comparisons test.) All data are 
mean ± sem. 
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Figure 2.6 Fluorescence recovery after photobleaching of perinuclear PKAcat 
a. Fluorescence recovery after photobleaching. Untransfected cells (control) were untreated (top) or treated with 100 nM 
isoproterenol (bottom) for 30 minutes before live imaging. Then cells were photobleached (white box) at 0.5 min and 
fluorescence recovery was monitored for 5 minutes after photobleaching. b. Quantitation of photobleaching. 
Fluorescence in the region of interest (white box in a) was measured over 5.5 minutes (before and after photobleaching). 
Fluorescence over time was normalized to the pre-photobleached fluorescence intensity. (n = 3; Control untreated vs Iso 
P = 0.0027; Dyn1-K44E untreated vs Iso P = 0.0030; Control untreated vs Dyn1-K44E untreated, P = 0.9502; Control 
Iso vs Dyn1-K44E Iso, P = 0.9569; ordinary one-way ANOVA, Sidak’s multiple comparisons test.) All data are mean ± 
sem. 
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Figure 2.7 Endocytosis blockade reduces β2AR-stimulated PCK1 transcription 
Cells were transfected with either a. mCherry-Dyn1 (Control) or mCherry-Dyn1-K44E, or b. Control siRNA or CHC17 
siRNA, then untreated or treated with 100 nM isoproterenol up to two hours. qRT-PCR was performed on these samples 
for PCK1 and GAPDH. (Dyn1 vs Dyn1K44E n = 6, Time P < 0.0001, Transfection P = 0.0476, two-way ANOVA.) (Control 
siRNA vs CHC17 siRNA n = 6, Interaction P = 0.0260, Time P < 0.0001, Transfection P < 0.0001, P < 0.005 for time = 
60 and 90 min; two-way ANOVA, Sidak’s multiple comparisons test.) All data are mean ± sem. Nuclear cAMP signaling 
cascade responses are shown in the same time scale (up to 60 minutes) in cells transfected with control siRNA or 
CHC17 siRNA. c. Immunoblot analysis of PKAcat from nuclear samples treated with 100 nM Iso. d. Immunoblot analysis 
of CREB phosphorylation from whole cell lysates after 100 nM Iso treatment. e. qRT-PCR quantitation of cells treated 
with 100 nM Iso. 
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Figure 2.8 Summary model 
a, b. The profile of overall cellular cAMP signaling after β2AR activation can be described by two distinct phases - an 
initial peak phase characterized by high levels of cAMP subsequently followed by a plateau phase distinguished by a low 
level of constant cAMP. c. Corresponding changes with PKAcat occur during these distinct cAMP phases. At basal state, 
PKAcat is non-uniformly distributed throughout the cytoplasm, and highly concentrated at a perinuclear region. During 
the peak phase, PKAcat is released from the perinuclear region and redistributed throughout the cytoplasm. During the 
plateau phase, PKAcat returns to the perinuclear region and has begun to enter the nucleus. 
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Supplemental Figure 2.1 Effects of endocytic blockade on the cAMP signaling pathway 
a. Endocytic blockade by dominant negative dynamin (Dyn1-K44E) reduces cAMP over time. Cells stably expressing 
cAMP luminescence biosensor (GloSensor-IRES-Rluc) were transiently transfected with pcDNA3 (Control) and mCherry-
Dyn1-K44E. Cells were untreated or treated with 100 nM Isoproterenol at 0 minutes and imaged for 20 minutes. All  
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  conditions are normalized to the max of the Control 100 nM Iso condition (window averaging 5 proximal values). b. 
Endocytic blockade effects on β2AR internalization. Three methods of endocytic inhibition are assayed by β2AR 
internalization. Prior to 100 nM Iso addition, cells stably expressing FLAG-β2AR are either transiently transfected with 
pcDNA3 (Control) or mCherry-Dyn1-K44E, ASN siRNA (Control) or CHC17 siRNA, or pretreated with DMSO (Control) 
and 30 μM Dyngo-4A for 15 minutes. Then, cells were untreated or treated with 100 nM Iso for 30 minutes. Surface cell 
receptor was determined by M1-FLAG-647 antibody and internalization was subsequently calculated per condition. c. 
Images of endocytic blockade methods on β2AR internalization. Cell surface Β2ARs were labeled using M1-FLAG-647 in 
cells stably expressing FLAG-β2AR. After 30 minutes of 100 nM Iso, cells were imaged by spinning disk confocal 
microscopy. Images of representative single slices are shown depicting the amount of β2AR internalization after 30 
minutes isoproterenol. d. Effects of endocytic blockade on peak cAMP luminescence. Cells stably expressing cAMP 
luminescence biosensor (GloSensor-IRES-Rluc) were transiently transfected with pcDNA3 (Control) or mCherry-Dyn1-
K44E, ASN siRNA (Control) or CHC17 siRNA, or pretreated with DMSO (Control) and 30 μM Dyngo-4A for 15 minutes. 
The peak luminescence value (window averaging 5 proximal values) of each sample was determined and normalized to 
the corresponding control iso condition. e. Endocytic blockade by multiple methods reduces β2AR-stimulated PCK1 
transcription. We employed three methods of endocytic inhibition are assayed by β2AR internalization. Cells were either 
transiently transfected with pcDNA3 (Control) or mCherry-Dyn1-K44E, ASN siRNA (Control) or CHC17 siRNA, or 
pretreated with DMSO (Control) and 30 μM Dyngo-4A for 15 minutes. qRT-PCR was performed on cells untreated or 
treated with 100 nM iso for two hours. f. Isoproterenol stimulates cAMP luminescence over time. Cells stably expressing 
cAMP luminescence biosensor (GloSensor-IRES-Rluc) were untreated or treated with 100 nM, 10 nM, or 1 nM 
isoproterenol at 0 minutes and imaged for 20 minutes. All conditions are normalized to the max of the 100 nM Iso 
condition (window averaging 5 proximal values. g. cAMP fluorescence biosensor characterization in vitro. Cytoplasmic 
fraction prepared from HEK293 cells transiently expressing cpGFP-cAMP biosensor was treated with 100 μM IBMX, and 
different concentrations of cAMP. Fluorescence was recorded and the data was fit to a non-linear regression model 
(Sigmoidal, 4PL). Data are mean ± stdev, from one independent experiment. h. Kinetics of cpGFP-cAMP biosensor 
response. Cells transiently transfected with the cpGFP-cAMP biosensor and pcDNA3 (Control) or mCherry-Dyn1-K44E 
were imaged with 100 nM Iso added at 5 minutes. Each cAMP response was normalized to the peak response within 30 
minutes after iso addition. All data are mean ± sem, and from at least three independent experiments. *exception g. 
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Supplemental Figure 2.2 Gene-edited mNG2-PKAcat HEK293T cells 
a. Immunoblot of cells expressing unlabeled and labeled PKAcat. Immunoblot analysis on PKAcat (~42 kDa) was 
performed on samples from HEK293T cells stably expressing mNG21-10 only or mNG21-10 and mNG211-PKAcat. b. 
Identifying cells expressing mCherry-Dyn1-K44E. Cells expressing mCherry-Dyn1-K44E were identified to determine 
which cells would be used for analysis. 
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Supplemental Figure 2.3 Detection of nuclear PKAcat by live microscopy 
a. Visualizing PKAcat in the nucleus with live imaging. Gene-edited cells expressing endogenous mNG2-PKAcat were 
treated with 10 μM FSK and 500 μM IBMX for 60 minutes. b. Identifying cells expressing NLS-mNG21-10 IRES TagBFP. 
Cells expressing NLS-mNG21-10 IRES TagBFP were identified to determine which cells would be used for analysis.   
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Supplemental Figure 2.4 Fluorescence recovery after photobleaching curve fit 
Photobleaching recovery curves with non-linear fit. Recovery curves from Figure 2.6b are replotted so recovery begins a 
0 seconds. Each recovery curve was fit using non-linear regression and an exponential one-phase association model. 
The perinuclear iso condition (green) has a half-time of 45.36 s and fractional recovery of 49.45%. The perinuclear 
untreated condition (gray) has a half-time of 56.56 s and a fractional recovery of 17.67%. All data are mean ± sem. 
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Chapter 3: M2R inhibits β2AR-stimulated PCK1 
trasncription from the plasma membrane 
 
 
 
 
 
Grace Peng conceived of this project, generated constructs, conducted all experiments, and 
analysis, and wrote the manuscript presented in this chapter. Mark von Zastrow contributed to 
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3.1 Abstract 
 Cardiac G protein-coupled receptors (GPCRs) are important in regulating heart function. 
These GPCRs detect extracellular stimuli (agonists) and generate an intracellular signaling response 
crucial to controlling heart rate and cardiac muscle contractility. Disordered signaling is observed in 
pathologies including congestive heart failure, cardiomyopathy and hypertension. β2-adrenergic 
receptors (β2ARs) and M2 muscarinic acetylcholine receptors (M2Rs) are GPCRs that are co-
expressed in cardiac muscle cells and operate to exert largely opposing modulatory effects. β2ARs 
stimulate cardiac excitability primarily by coupling to the heterotrimeric G protein Gs. Conversely, 
M2Rs reduce excitability by coupling to Gi. Both GPCRs internalize after agonist-induced 
activation. Recent work has shown that some GPCRs, including β2ARs, initiate a second phase of 
signaling by coupling to Gs on endosomes. Here we find that M2Rs, are capable of entering the 
same endosomes as β2ARs and are also able to inhibit the β2AR endosomal signal. These findings 
provide insight into a fundamentally new aspect of cellular GPCR signaling, namely whether 
endocytosis facilitates functional coordination between these GPCRs or, alternatively, if 
endocytosis isolates a subset of β2AR signaling actions from M2R modulation, which is 
fundamental to understanding the physiological relevance of cardiac endosomal signaling.  
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3.2 Introduction 
Cells sense their extracellular environment via external stimuli and transmit signals to mediate a 
proper response. Many of these responses are controlled by G protein-coupled receptors 
(GPCRs). GPCRs are responsible for the signal transmission of many processes including cell 
motility and migration, vision, taste and smell. Classically, a stimulus known as an agonist binds to 
activate the receptor and trigger intracellular signaling (Sorkin & von Zastrow, 2002).  
 
In the heart, adrenaline and acetylcholine are agonists for β-adrenergic and muscarinic 
acetylcholine receptors, respectively. These G protein-coupled receptors (GPCRs) are co-
expressed in cardiac muscle cells (myocytes) and trigger physiologically opposing actions through 
intracellular G protein signaling cascades (Brodde & Michel, 1999). β2ARs and M2Rs 
predominantly couple to two distinct classes of heterotrimeric G proteins, Gs and Gi respectively. 
Historically, these G proteins were classified based on their ability to stimulate (Gs) or inhibit (Gi) the 
adenylyl cyclase (AC) enzymes that generate the intracellular second messenger cAMP (Alberts et 
al., 2002). In the heart, β2AR-Gs activation of AC increases cAMP concentration to enhance the 
strength of cardiac contraction (Brodde & Michel, 1999; Dzimiri, 1999; Nikolaev et al., 2006; 
Rochais et al., 2006). M2R-Gi activation inhibits AC and activates G-protein activated inwardly 
rectifying K+ (GIRK) channels, to effectively antagonize the β2AR effects physiologically (Aprigliano 
et al., 1997; Brodde & Michel, 1999; Harvey, 2012; Harvey & Belevych, 2003; Nikolaev et al., 
2006). In cardiac cells, GIRK channels contribute to setting resting membrane potential and 
increase the rate of cardiac repolarization after an action potential (Brodde & Michel, 1999; Harvey, 
2012).  
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For β2AR and M2R to maintain their antagonistic relationship, both receptors must be present at 
the same membrane. However, both the β2AR and M2R internalize rapidly after agonist-induced 
activation (Robin Pals-Rylaarsdam et al., 1997; Reiner & Nathanson, 2012; von Zastrow & Kobilka, 
1992), which redistributes each receptor and potentially disrupts this required functional interaction 
at the plasma membrane. Endocytosis has well known effects in modulating GPCR number and 
activity after prolonged or repeated exposure to agonist, but it is not traditionally thought to impact 
the signal itself because internalized GPCRs were believed to be functionally inactive. Recent 
results suggest, in contrast, that the β2AR and some other Gs-coupled GPCRs mediate a discrete, 
second phase of GPCR and Gs activation from endosomes (Calebiro et al., 2009; Ferrandon et al., 
2009; Irannejad et al., 2013; Kotowski et al., 2011).  
 
Endosomal signaling of GPCRs is a new area cell biology that has grown vastly in the last decade. 
The majority of the evidence support signaling from endosomes by Gs-coupled receptors, however 
other subtypes (Gi, Gq) have also been found capable as well. Yet, how endosomal signaling 
affects the integrative cellular response remains unexplored. The antagonistic relationship between 
β2AR and M2R remains a particularly interesting example to study as the β2AR is known to signal 
from the endosome, and β2AR and M2R act through a common effector protein, adenylyl cyclase, 
to modulate the cellular signaling response.  
 
On first principles, we reason that both receptors must be in the same membrane for their 
antagonist relationship to exist. Both β2AR and M2R localize to early endosomes marked by early 
endosome antigen 1 (EEA1) (Robin Pals-Rylaarsdam et al., 1997; Reiner & Nathanson, 2012; von 
Zastrow & Kobilka, 1992), therefore we think it likely that both receptors internalize to the same 
endosomes. To further investigate how endocytosis affects the functional relationship between 
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β2AR and M2R, we utilize a real time cAMP assay useful for detecting rapid effects, as it can 
provide time resolution on the order of seconds. In the heart, β2ARs mediate acute actions that fall 
well within this time window, but β2ARs also mediate important long-term effects. Many of these 
are mediated by control of downstream transcription. Recent work suggests that β2AR-Gs cAMP 
production from endosomes is particularly important to these long-term effects, and particular 
transcripts have been defined that are selectively induced by cAMP generated from endosomes 
(Tsvetanova & von Zastrow, 2014). PCK1 is robustly induced after ~2 hours of β2AR activation and 
is a sensitive detector of cAMP generated from endosomes relative to the plasma membrane 
(Tsvetanova & von Zastrow, 2014). 
 
Here we investigate how endocytosis changes the functional relationship between the β2AR and 
M2R by looking at endocytosis-dependent cAMP-transcription. We start with the hypothesis that 
M2Rs function in endosomes to inhibit β2AR-Gs-AC signaling. This study uses HEK293 cells as an 
experimentally advantageous model based on known occurrence of β2AR-Gs-AC activation in both 
the plasma membrane and endosomes (Irannejad et al., 2013), and the availability of well-defined 
manipulations for perturbing receptor trafficking (Hausdorff et al., 1991; McCluskey et al., 2013; 
Seibold et al., 2000; Vassilopoulos et al., 2009). HEK293 cells are also a useful experimental model 
because they express β2ARs as the major endogenous beta-adrenergic receptor (Violin et al., 
2008), lack endogenous M2R activity (no detectable carbachol response without expression of 
recombinant M2Rs), and recombinant M2Rs confer both acute and long-term modulation of 
endogenous β2AR signaling in these cells. We additionally seek to determine whether M2Rs 
mediate a long-term effect on β2AR signaling from endosomes through cAMP-dependent 
transcriptional control, using the previously established target gene, PCK1, as a readout. This 
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assay will complement the acute cAMP accumulation, is more specific to endosomal cAMP 
signaling.   
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3.3 Results 
β2AR and M2R transit a shared population of endosomes 
We posit that for M2R to modulate the β2AR signal, both receptors need to be on the same 
membrane, in the case of endosomal signaling, this requires both receptors to be in the same 
endosome. Here we test whether β2AR and M2R redistribute to different endosomes or converge 
at the same endosomes after agonist addition of both receptors. 
 
β2AR and M2R are both known to internalize to early endosome antigen 1 (EEA1) positive 
endosomes (Robin Pals-Rylaarsdam et al., 1997; Reiner & Nathanson, 2012; von Zastrow & 
Kobilka, 1992), but whether they internalize to the same EEA1 positive endosomes is not known. 
We first determined whether both β2ARs and M2Rs internalize to the same endosomes. In 
HEK293 cells, we overexpressed HA-β2AR and FLAG-M2R and used fluorescently conjugated 
anti-HA and anti-FLAG antibodies to label each receptor. We found that both β2ARs and M2Rs 
colocalize on the same endosomes after agonist induced internalization with saturating amounts of 
isoproterenol and carbachol (agonists for β2AR and M2R respectively; Figure 3.1a). 
 
We next assessed this overlap between β2AR and M2R in the cell qualitatively by identifying 
subpopulations of endosomes (early, late and recycling) with fluorophore-tagged endosomal 
markers (EEA1, Rab7, Rab4 and Rab11, respectively) (Grant & Donaldson, 2009; Rink et al., 
2005). Using the same method to label and detect β2AR and M2R, we additionally overexpressed 
each endosomal marker and looked at cells before and after isoproterenol and carbachol 
treatment (Figures 3.1b-f). Before agonist addition, both receptors are primarily detected at the 
plasma membrane (Figure 3.1b). After agonist-induced internalization with isoproterenol and 
carbachol, both receptors internalized to EEA1 positive endosomes (Figure 3.1c). β2AR and M2R 
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colocalize together with Rab4 early/recycling endosomes (Figure 3.1d) but not late (Rab7) or 
Rab11 recycling endosomes (Figures 3.1e-f) after 30 minutes of isoproterenol and carbachol 
addition. These results show that M2R transits a shared population of endosomes as β2AR. This 
initial result allows for the possibility that M2R could affected β2AR endosomal signaling by being 
at the same endosome. 
 
β2ARs are in an active conformation in a subpopulation of endosomes and, in these endosomes, 
they can also activate Gs (Irannejad et al., 2013). We used established conformationally sensitive 
nanobody biosensors a new class of reagents derived from nanobodies, which selectively 
recognize particular conformational states of the GPCR or G protein. We expressed Nb80-EGFP 
and Nb37-mCherry to detect activated β2AR and Gs, respectively, and examined whether the 
β2AR and M2R population of endosomes also contain activated β2AR and Gs. Using our previous 
strategy to image epitope-tagged HA-β2AR and FLAG-M2R, we expressed each nanobody 
biosensor and imaged cells in the presence and absence of isoproterenol and carbachol (Figures 
3.2a-c). Before agonist addition, Nb80-EGFP is in diffuse in the cytoplasm, and β2AR and M2R 
remain on the plasma membrane (Figure 3.2a). After addition of isoproterenol and carbachol, β2AR 
and M2R internalize to endosomes which also contain Nb80-EGFP (Figure 3.2b). To detect 
activated Gs, we used Nb37-mCherry, which like Nb80-EGFP is also diffusely in the cytoplasm 
before agonist addition. After stimulation of β2AR with isoproterenol, Nb37-mCherry localized to 
both the plasma membrane and endosomes (Figure 3.2c). β2AR and M2R additionally localized to 
the locations as Nb-37-mCherry. These data suggest that M2R colocalizes with activated β2AR 
and activated Gs, therefore M2R localizes to endosomes which allows for the possibility it to 
modulate the β2AR signal. 
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Characterization of M2R internalization 
Though M2R has been found at early endosomes, the components involved in the internalization 
pathway remain unclear. Many of the previous studies conflict in determining which components 
are required in this pathway. Some reports claim a caveolin-independent, clathrin-independent and 
dynamin-independent pathway, and thus a very non-traditional pathway distinct from β2AR 
(Delaney et al., 2002; Roseberry & Hosey, 2001). More recent reports contradict these earlier 
findings and determine a necessity for clathrin and dynamin (Jones et al., 2006). With the 
advancement of siRNAs and pharmacological inhibitors, a new look at the M2R internalization 
pathway will help elucidate the important components of this pathway. Furthermore, to determine 
the importance of endocytosis on the signaling by M2R, we will need the ability to block 
endocytosis. 
 
First, we used a previously established flow cytometry-based assay to determine the number of 
surface-labeled receptors in the presence and absence of agonist to determine the amount of 
internalization under different conditions. Using a cell line stably expressing FLAG-M2R, we found 
that M2R internalization begins within 5 minutes after carbachol treatment and reaches steady 
state after 30 minutes of carbachol treatment (Figure 3.3a). Next, to test whether M2R 
internalization is truly clathrin- and dynamin- independent in HEK293 cells, we blocked endocytosis 
by using siRNA against clathrin heavy chain (CHC17) and a chemical inhibitor against dynamin 
(Dyngo-4A) (McCluskey et al., 2013; Vassilopoulos et al., 2009). We found endocytosis of M2R 
was greatly reduced when clathrin and dynamin were perturbed (Figures 3.3b&c), suggesting that 
M2R internalization is clathrin- and dynamin-dependent. 
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β2AR internalization is well established and also clathrin- and dynamin-dependent. This poses a 
problem, if both receptors internalize using the same components, we cannot selectively block the 
internalization of one receptor to determine how endocytosis affects their functional relationship. 
We focused on M2R internalization mutants because it is known that β2AR signals from the 
endosome. We can use M2R internalization mutants to determine whether endosomal M2R 
modulates the β2AR endosomal signal. 
 
Intracellular loop 3 of the M2R contains two Ser/Thr clusters that are phosphorylated by GRK2, 
which are important for desensitization and internalization (R. Pals-Rylaarsdam & Hosey, 1997; R. 
Pals-Rylaarsdam et al., 1995). We obtained an intracellular loop 3 deletion mutant (M2R Δi3, 
residues 232-372; Figure 3.3d) previously used in obtaining the crystal structure of activated M2R. 
We also generated a previously described mutant where the two Ser/Thr clusters are mutated to 
Ala to prevent internalization (M2R NC8, Figure 3.3d). We generated stable cell lines of these 
mutants and confirmed internalization deficiency by microscopy. We imaged cells overexpressing 
Rab5-EGFP to mark early endosomes, and FLAG-M2R, FLAG-M2R Δi3, or FLAG-M2R NC8 
before and after a 30 minutes carbachol treatment (Figure 3.3e). In all cases, M2R was found at 
the endosome before carbachol treatment. As expected, wildtype M2R was primarily found at early 
endosomes marked by Rab5 after carbachol addition. In contrast, both M2R Δi3 and M2R NC8 
were found primarily at the plasma membrane. These images suggest that the M2R Δi3 and M2R 
NC8 mutants do not internalize efficiently. We additionally performed flow cytometric analysis to 
characterize internalization of the M2R mutants. First, we compared the receptor expression levels 
of each M2R stable cell line, and found them to be similar (Figure 3.3f). Next, we found that after 
30 minutes of carbachol treatment, both the M2R Δi3 and M2R NC8 mutants had greatly reduced 
internalization (Figure 3.3g), consistent with our imaging results. Here, we verified that M2R 
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internalization is clathrin- and dynamin-dependent. Additionally, we validated two M2R 
internalization mutants for use in our functional experiments investigating the impact of M2R 
endocytosis on β2AR signaling.  
 
M2R inhibits β2AR acute cAMP signaling 
Functional antagonism between β2AR and M2R signaling has been well described (Aprigliano et 
al., 1997; Brodde & Michel, 1999), but how much of M2R inhibition β2AR occurs from the plasma 
membrane or the endosome is unknown. First, we verified that M2R impacts β2AR signaling in 
HEK293 cells by measuring cAMP production when β2AR and β2AR and M2R are stimulated. To 
do so, we express a cAMP luminescence biosensor that increases in luminescence as more cAMP 
is detected. We stimulated endogenous β2ARs only and simultaneously with overexpressed M2Rs 
to determine how much cAMP inhibition M2R caused. We found that M2R caused a moderate 
inhibition (Figure 3.4a) in β2AR-stimulated cAMP. 
 
To understand how much inhibition M2R imparts at endosomes, we first confirmed that endocytic 
blockade by the chemical inhibitor Dyngo-4A, moderately reduced the amount of cAMP produced 
by β2AR using the same cAMP luminescence biosensor as before (Figure 3.4b, blue circles and 
triangles). We reasoned that if M2R inhibits β2AR-stimulated cAMP production at the endosome, 
then blocking both β2AR and M2R endocytosis would reduce the degree of M2R inhibition on 
β2AR-stimulated cAMP.  
 
Here, we find that M2R inhibition of β2AR-stimulated cAMP is approximately 30% (Figure 3.4b, 
blue circles and gray squares). We tested how M2R inhibition of β2AR-stimulated cAMP was 
impacted by endocytic blockade, and found that M2R reduced β2AR-stimulated cAMP by 
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approximately 20% when endocytosis of both receptors was blocked (Figure 3.4b, blue and gray 
triangles). This would initially suggest that M2R does inhibit β2AR at the endosome given our 
previously stated rationale, however when tested and compared by one-way ANOVA, this 
difference is not significant.  
 
Our assay may not be sensitive enough to detect M2R inhibition in the endosome or M2R inhibition 
of β2AR-Gs-AC signaling primarily occurs from the plasma membrane. To determine which of 
these were the case, we sought other methods to investigate the effect of M2R inhibition on β2AR-
Gs-AC signaling. Next, we used a biochemical homogenous time resolved fluorescence assay, and 
measured the amount of cAMP produced per sample after 30 minutes of agonist addition. The 
addition of isoproterenol increased the amount of cAMP compared to untreated cells as expected 
(Figure 3.4c, blue circles). Co-stimulation with carbachol led to about a 55% reduction in cAMP 
production (Figure 3.3c blue circles and gray squares). When endocytosis was blocked, M2R 
inhibition of β2AR-stimulated cAMP was approximately 50% (Figure 3.4c blue and gray triangles). 
While these data are consistent with the luminescence assay, they also lacked significance by one-
way ANOVA. 
 
Lastly, we used the M2R internalization mutants that we previously validated to determine whether 
we could detect a difference in the amount of inhibition between M2R wildtype and internalization 
mutant on β2AR-Gs-AC signaling. We first checked the amount of cAMP produced when β2AR 
and M2R were concomitantly activated (Figure 3.4d). We find that the max amount of cAMP 
produced is relatively similar across all M2R types (wildtype and internalization mutants). Wildtype 
M2R inhibited β2AR-stimulated cAMP production by about 30%, but the M2R internalization 
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mutants inhibited β2AR-stimulated cAMP by about 25% (Figure 3.4e). Again, these data were not 
found to be significant by one-way ANOVA.  
 
Even if our assays were not sensitive enough to detect how much M2R affects endosomal β2AR-
stimulated cAMP production, our data do suggest that most, if not all, M2R inhibition on the β2AR-
Gs-AC signal occurs at the plasma membrane. Though we could not concretely determine whether 
M2R modulates the endosomal β2AR-Gs-AC signal, we next used a more sensitive read out to test 
the role of M2R in its impact on downstream β2AR signaling. 
 
M2R intracellular loop 3 is required for inhibition of cAMP-dependent transcription 
Previous work found a set of genes that are specifically induced when the β2AR-Gs-AC pathway 
was activated when endocytosis was allowed. The transcription of one gene, PCK1, is significantly 
induced when endocytosis of the β2AR is allowed compared to when endocytosis of β2AR is 
blocked, indicating that PCK1 is strongly tied to cAMP produced from the endosome (Tsvetanova 
& von Zastrow, 2014). Here, we use PCK1, to interrogate whether M2R inhibits the endocytic-
sensitive β2AR transcriptional target. We verified by quantitative PCR (qRT-PCR) that PCK1 
significantly induced when endocytosis was allowed, but greatly reduced when endocytosis was 
blocked (Figure 3.5a). Next, we determined the effect of M2R activation the β2AR-stimulated PCK1 
induction. When stably expressing M2R was coactivated with β2AR, PCK1 induction was reduced 
greatly, by about 40% (Figure 3.5b). Because PCK1 is an endocytosis-sensitive target, these data 
suggest that M2R is capable of inhibiting β2AR-Gs-AC signaling.  
 
We do not have direct evidence for activated M2R in the endosome and from the endosome inhibit 
β2AR-Gs-AC signaling at the endosome, we used our internalization mutants to help characterize 
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the inhibition of PCK1 by M2R. We performed qRT-PCR in cell lines stably expressing M2R 
wildtype and internalization mutants (Δi3 or NC8). We found that M2R reduced β2AR-stimulated 
PCK1 induction by approximately 50% (Figures 3.5c&d; red), while M2R Δi3 and M2R NC8 
reduced β2AR-stimulated PCK1 induction by approximately 10% and 40% respectively (Figures 
3.5c&d; dark and light gray). These results suggest that wildtype M2R is most capable in inhibiting 
β2AR-stimulated PCK1 induction, as M2R NC8 has reduced inhibition comparatively. These results 
also suggest that M2R intracellular loop 3 is required for the inhibition of β2AR-stimulated PCK1 
induction, as the removal of intracellular loop 3 severely reduced the ability of M2R Δi3 to modulate 
the induction of PCK1 by the β2AR.  
 
Dynamin is required for M2R-mediated inhibition of β2AR-stimulated PCK1 transcription 
We further investigated what was required of this M2R-mediated inhibition of PCK1 transcription. 
While of β2AR-stimulated PCK1 induction is primarily associated with the endosomal signal, we 
assume that there is some amount that is attributed to the plasma membrane, as inhibition of 
endocytosis does not completely eliminate PCK1 transcription (Figure 3.5a). Though there are 
unclear differences between the two M2R internalization mutants, they both have reduced 
inhibition of PCK1 transcription compared to wildtype M2R. We hypothesized that there may be 
continued inhibition of PCK1 transcription through the plasma membrane signal, because the M2R 
internalization mutants are unable to desensitize and will consequently generate a stronger 
inhibitory effect at the plasma membrane. 
 
To determine whether the inhibitory effect by the M2R internalization mutants were on the β2AR  
plasma membrane or endosomal signal, we tested the effects of endocytic blockade when both 
β2AR and M2R were stimulated. When endocytosis was inhibited by the chemical inhibitor of 
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dynamin, Dyngo-4A, wildtype M2R had no effect on the β2AR-stimulated PCK1 transcriptional 
response (Figure 3.6a). This would suggest that endocytosis is important for M2R inhibition of 
PCK1 transcription. To confirm this result, we next tested the effect of endocytic blockade on both 
M2R internalization mutants. In both cases, we found that when endocytosis was blocked, M2R 
Δi3 and M2R NC8 both did not have any effect on β2AR-stimulated PCK1 transcription (Figures 
3.6b&c). This result was contrary to the idea that endocytosis of M2R is important for its inhibition 
of PCK1 transcription. 
 
Our results here show that the M2R has been found with β2AR at both the plasma membrane and 
the endosome, and is therefore advantageously positioned to for β2AR signaling inhibition. M2R 
receptor inhibits the β2AR cAMP signaling response at different levels and at different locations. 
M2R inhibition of β2AR signaling occurs at the acute level of the overall cAMP response, and at the 
long-term level of cAMP-dependent transcriptional response. The propagation of these signaling 
events occur at different places within the cell, the overall cellular cAMP response primarily occurs 
at the plasma membrane while cAMP production tied to PCK1 transcription is specific to the 
endosome.  
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3.4 Discussion 
Functional antagonism between β2AR and M2R signaling was previously described when GPCR 
signaling was thought to occur primarily from the plasma membrane. The new area of GPCR 
endosomal signaling has opened up many questions including whether this well described 
functional antagonism occurs at the endosome as well as the plasma membrane. The present 
study stably overexpressed M2Rs in HEK293 cells (which endogenously express β2AR) 
investigated whether M2R endosomal signaling exists, and whether it contributes to the integrated 
cellular response by modulating the effects of the β2AR at the endosome.  
 
Our data shows that M2Rs exist in the same endosomes as activated β2AR and Gs protein. This 
suggested that M2Rs may be capable of inhibiting β2AR from the endosome in addition to the 
plasma membrane. We investigated whether M2Rs are active at the endosome and inhibit the 
β2AR signaling cascade at the endosome. Consistent with previous studies, we found that M2Rs 
inhibit β2AR-elicited cAMP production using a live cAMP production assay. To determine whether 
M2R inhibited the β2AR-stimulated endosomal cAMP, we inhibited the internalization of either both 
β2AR and M2R or M2R only. Endocytic blockade of both receptors using a chemical inhibitor for 
dynamin showed that the inhibitory effect of M2R was slightly reduced or had no significant 
change. Work with the M2R internalization mutants also showed a similar degree of inhibition on 
β2AR-stimulated cAMP production. Together, these results suggested that the inhibitory effect on 
β2AR-stimulated cAMP by M2R is similar at the plasma membrane and the endosome. 
  
β2AR-dependent PCK1 induction was also markedly (but not completely) reduced by carbachol-
induced activation of wildtype M2Rs. Previous work indicated that β2ARs induce PCK1 in HEK293 
cells primarily though generating cAMP from endosomes (Tsvetanova & von Zastrow, 2014). Taken 
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together, these results suggest that M2Rs modulate the β2AR signal at endosomes. M2R 
internalization mutants also inhibited β2AR-stimulated PCK1 transcription to a lesser degree than 
wildtype M2R. This result suggested that M2Rs (wildtype and internalization mutants) were all 
capable of inhibiting the β2AR endosomal signal, however the mechanism of M2R inhibition 
remains unanswered. 
 
The initial imaging results showed that M2R exists at endosomes with activated β2AR and Gs 
protein was promising. Though M2R was found to inhibit the β2AR endosomal signal, there was no 
direct or conclusive evidence to suggest that M2Rs are active at the endosome. What seems to be 
difficult to reconcile is the data where the two M2R internalization mutants have different abilities to 
inhibit β2AR-stimulated PCK1 transcription. This would suggest that M2R can inhibit the β2AR 
endosomal signal from a different membrane, contrary to our original assumption. This is formally 
possible and therefore more experiments will need to be done to test this hypothesis. 
 
We have come up with a few possible explanations with how M2R inhibition of β2AR-stimulated 
PCK1 transcription does not require both receptors to exist at the same membrane. M2R at the 
plasma membrane may greatly inhibit the global cAMP levels required to allow PKAcat to 
effectively diffuse into the nucleus (Figure 3.7a). As previously described in Chapter 2, we 
hypothesize that the β2AR endosomal signal is promoted through the combined efforts of low 
global cAMP and high local endosomal cAMP to allow for small but significant concentrations of 
PKAcat to diffuse into the nucleus. Our results weakly support a stronger M2R inhibitory effect at 
the plasma membrane than at the endosome (Figure 3.4). We hypothesize here, that the M2R 
inhibitory effect at the plasma membrane is great, and reduces the global cAMP level significantly 
during the ‘plateau phase’ (see Chapter 2, Figure 2.1f). Without this low global cAMP level, slowed 
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effective diffusion of PKAcat cannot exist, and PKAcat cannot travel far enough to enter the 
nucleus. 
 
Another possibility is for M2R to affect the localization of endosomal adenylyl cyclases (AC). 
Previous work investigating the D1 dopamine receptor indicated that AC5 reside intracellularly at 
internal vesicles (Kotowski et al., 2011). AC5/6 has been previously described to reside at plasma 
membrane and internally in the cell, though the trafficking of AC5/6 is not known. Recent work 
suggests that Gs proteins can promote the trafficking of certain ACs after Gs activation (Lazar, 
2019). If AC5/6 or another AC traffics to the endosome through Gs protein activation, could Gαi 
protein activation prevent this trafficking as an inhibitory mechanism (Figure 3.7b)? 
 
Lastly, we describe the necessity of the intracellular loop 3 for M2R inhibition on β2AR-stimulated 
PCK1 transcription. Without the third loop, PCK1 transcription is not inhibited (Figure 3.6b). The 
M2R intracellular loop 3 is a major regulatory domain known to to be important for internalization 
and desensitization. Additionally, because of its large size (residues 210-387), there may reside 
multiple motifs important in the regulation of signaling. One such way M2R intracellular loop 3 may 
play a role in the inhibition of β2AR-stimulated PCK1 transcription is to recruit an additional protein 
that regulates cytoplasmic or endosomal cAMP (either through reduced synthesis or promotion of 
degradation, Figure 3.7c). This would reduce intracellular / endosomal cAMP and consequently 
reduce the cAMP-dependent PCK1 transcriptional response. 
 
Much future work needs to be done to determine if M2R inhibits β2AR signaling through any of 
these possibilities. Additionally, an inherent problem with interpreting signaling experiments based 
on cAMP is that is that the results are correlative. Development of biosensors that detect activation 
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of receptors and G proteins, as an independent and more incisive approach together with the 
cAMP signaling experiments will also help determine whether M2R is capable of endosomal 
signaling. 
 
Further open questions include 1) how the endosome signal is influenced by receptor complexes 
such as β1AR/β2AR heterodimers (Lavoie et al., 2002), 2) the relationship between endosome 
activity and β2AR localization to caveolae at the plasma membrane (Odley et al., 2004; Rybin et al., 
2000), and 3) whether β2ARs, capable of Gi-coupling (Daaka et al., 1997; Xiao et al., 1995), do so 
in endosomes. 
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3.6 Materials and methods 
Cell Culture 
Human HEK293 cells were grown in DMEM (Gibco, 11965) supplemented with 10% fetal bovine 
serum (UCSF Cell Culture Facility). Cells were grown at 37°C and 5% CO2 in a humidified 
incubator. HEK293 stable cell lines (FLAG-M2R, FLAG-M2R Δi3, FLAG-M2R NC8) were generated 
by transfection of the plasmid of interest followed by antibiotic selection. 
 
Imaging 
Cells were plated on 35 mm imaging dishes (MatTek, P35G-1.5-14-C) coated with poly-L-lysine 
(Sigma, P8920) and transfected with 4 μL Lipofectamine 2000 (Invitrogen, 11668) and DNA 24 
hours before imaging. 
Table 3.1 Amounts of transfected DNA constructs for imaging experiments 
 
Plasmid Amount (ng) 
pcDNA3.1+ FLAG-β2AR 1000 
pcDNA3 HA-β2AR 1000 
pcDNA3.1+ zeo FLAG-M2R 1000 
pcDNA3.1+ zeo FLAG-M2R Δi3 1000 
pcDNA3.1+ zeo FLAG-M2R NC8 1000 
EEA1-DsRed 300 
Rab4-mCherry 300 
Rab5-EGFP 300 
Rab7-EGFP 300 
Rab11-EGFP 300 
Nb80-EGFP 100 
Nb37-mCherry 100 
Gαs 600 
myc-Gβ 300 
Gγ 100 
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First, surface receptors (HA-β2ARs and/or FLAG-M2Rs) were labeled with fluorescently conjugated 
HA (Invitrogen, A21287 or MBL international, M180-A64) or M1-FLAG antibodies Sigma, F-3040 
with Invitrogen, A20173 or A20174) antibody. 
 
Images were acquired on a Nikon Ti inverted spinning disk confocal microscope (Yokogawa CSU-
22) with a custom 405-, 488-, 561- and 640-laser launch, with an Apo TIRF 100x/1.49 NA Oil 
objective (Nikon) and a Photometrics Evolve Delta EMCCD camera controlled by Nikon Elements 
software. Cells were kept in a temperature- and humidity-controlled chamber (Okolab) during 
imaging. 
 
Fixed cell imaging 
After labeling surface receptors, cells were untreated or treated with 10 μM isoproterenol (Sigma, 
I6504) and 10 μM carbachol (Sigma, C4382) at 37°C to induce β2AR and M2R internalization, 
respectively. After 30 minutes of agonist treatment, cells were placed on ice and washed 3 times 
with cold. Then cells were fixed with 3.7% formaldehyde (Fisher, F79) in modified BRB80 buffer (80 
mM sodium PIPES, 1 mM MgCl2, 1 mM CaCl2) for 20 minutes. Cells were washed with PBS, 
followed by a TBS wash. Cells were washed once more in PBS and mounted on glass slides with 
ProLong Gold Antifade mounting media (Invitrogen, P10144). Slides were stored for a minimum of 
24 hours to allow mounting media to dry before imaging. 
 
Live imaging 
Cells were imaged in imaging media (DMEM without phenol red (Gibco, 31053) supplemented with 
30 mM HEPES). Images were acquired before and after 30 minutes of agonist treatment. 
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Flow cytometry analysis of receptor internalization 
Cell surface fluorescence of HEK293 cells stably expressing FLAG-M2R, FLAG-M2R Δi3, FLAG-
M2R NC8, was measured to determine relative receptor expression and receptor endocytosis. 
Cells were incubated with 10 μM carbachol for 30 minutes at 37°C to internalize receptors to 
steady state. After treatment, cells were washed with cold PBS three times, then incubated with 1 
μg/ml AlexaFluor647-conjugated (Invitrogen, A20173) M1 mouse anti Flag monoclonal (Sigma, F-
3040) antibody at 4°C for 40 minutes on a shaker. Cells were mechanically lifted and mean 
fluorescence was read by flow cytometry for each sample on a FACSCalibur (BD). Each condition 
had three technical replicates per biological replicate.  
 
Endocytic inhibition 
Cells treated with Dyngo-4A were first changed to serum free media. Then DMSO (control) or 30 
μM Dyngo-4A was added to cells for 15 minutes to block endocytosis prior to the experiment. 
 
DNA constructs 
pcDNA3.1(+) zeo FLAG-M2R was previously generated in the lab by James Hislop. M2R mutant 
construction used this construct as the parent vector. The M2R intracellular loop 3 deletion mutant 
(pcDNA3.1 hM2 Δi3) was a gift from the Kobilka lab (Kruse et al., 2013). The area proximal to the 
intracellular loop 3 deletion was amplified from this plasmid to generate pcDNA3.1(+) zeo FLAG-
M2R Δi3. The M2R NC8 mutant has Ser/Thr to Ala in two phosphorylation clusters in intracellular 
loop 3, important for internalization (R. Pals-Rylaarsdam & Hosey, 1997). This mutant was 
generated using InFusion (Clontech) with gBlocks (IDT) containing the N cluster and C cluster of 
mutated phosphorylation sites and amplified pcDNA3.1(+) zeo FLAG-M2R. 
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cAMP luminescence assay 
Cells were grown to 70% confluency in a 10 cm dish and transfected with 2 μg pGloSensor-20F 
(Promega, E1171) and 24 μL Lipofectamine 2000 (Invitrogen, 11668). The next day, cells were 
preincubated with 1.6 mM D-luciferin (Gold Biotechnology, LUCNA-1g) in imaging media (DMEM 
without phenol red supplemented with 30 mM HEPES; Gibco 31053 and 15630 respectively) for 
40 minutes at 37°C and 5% CO2 in a humidified incubator and distributed into the central 16 wells 
of a poly-L-lysine coated 24 well plate (250 μL/well). Immediately before imaging, cells were treated 
with 250 μL imaging media only or imaging media with isoproterenol (100 nM final) and placed into 
a 37°C heated light-proof chamber, then imaged every 10 seconds for 20 minutes.  
 
Images were acquired by a 512 × 512 pixel electron multiplying CCD sensor (Hamamatsu C9100-
13) using Micro-Manager. ROIs were drawn around each well, and corresponding background 
ROIs were placed in an area without cells. Additionally, a dark plate control (empty plate) was also 
imaged to remove background. Matlab was used to measure intensity of each wells, to 
background subtract from the dark plate control and background ROIs in each run, and to control 
for vignetting effects from the placement of the camera (Irannejad et al., 2013). 
 
cAMP Homologous Time Resolved Fluorescence (HTRF) 
The HTRF kit detecting cAMP levels from CisBio (62AM4PEB) was used. HEK293 cells stably 
expressing FLAG-M2R were seeded into a 6 well plate. Cells were lifted from 3 wells of the 6 well 
plate and resuspended in 10 mL of media. Cells were spun down and then resuspended in 2 mL 
media. The assay was performed according to the manufacturer’s protocol. 
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Briefly, 25 μL of cells were plated in a in a white half-area 96 well plate. Then, 25 μL of media 
containing no agonist, 10 μM isoproterenol and/or 10 μM carbachol was added to each sample 
containing 500 μM isobutylmethylxanthine (IBMX; Sigma, I5879) and incubated for 30 minutes at 
37°C and 5% CO2 in a humidified incubator. After treatment, cells were lysed with first the addition 
of 25 μL lysis buffer with cAMP-d2 conjugate followed by 25 μL anti-cAMP Eu3+ cryptate 
conjugate. After lysis buffer was added, samples were incubated for one hour at room temperature 
and read on a Tecan M200 Infinite Pro controlled with Tecan i-control software.  
Initial analysis was done in Excel (Microsoft): 
 
1. Determine ratio of 665 to 620 signal. 
ratio = 	665nm × 10-620nm  
2. Background correct the ratio. Δ	ratio = ratio012 − ratio456  or   Δ	ratio = ratio0789:5 − ratio;5::456 
3. For interassay comparison, calculate ΔF and ΔFmax. 
∆F = 	 ratio0789:5 − ratio;5::456ratio;5::	456  
Use ∆>∆>max to compare assay to assay. 
 
For actual concentrations, open a tutorial in Prism (GraphPad) “RIA or ELISA: Interpolate unknowns 
from sigmoidal curve.” 
The log concentration of cAMP, and background corrected ratios for the standard curve and the 
unknowns were entered. Then using Prism, unknowns from the standard curve were interpolated 
using a 4PL sigmoidal model. 
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RNA extraction 
RNA was isolated from cells using the QIAshredder and RNeasy Mini kit (Qiagen, 79654 and 
74104, respectively). Briefly, after treatment, cells in a 6 well plate were placed on ice and washed 
once with cold PBS. Then cells were lysed, and RNA was extracted by following the 
manufacturer’s protocol. RNA was eluted in 30-50 μL of DEPC H2O, and the concentration of each 
sample was determined. 
 
Reverse transcription reaction 
cDNA was generated from RNA using the SuperScript III First-strand synthesis system (Invitrogen, 
18080-051). Briefly, 2 μg of RNA was used per reaction primed with oligo dT. The reverse 
transcription reaction was performed according to the manufacturer’s protocol.   
 
Quantitative Real Time PCR 
qRT-PCR was performed using a StepOnePlus (Applied Biosystems) instrument. cDNA generated 
from extracted RNA was used as the input for the qRT-PCR, with amplification by Power SYBR 
Green PCR master mix (Applied Biosystems, 4367659). Levels of transcripts were normalized to 
GAPDH. The primer pairs used were: 
Table 3.2 qRT-PCR primer sequences 
 
Primer Sequence 
GAPDH forward 5’-CTGCCCAAGATCTTCCATGT-3’ 
GAPDH reverse 5’-GACAAGCTTCCCGTTCTCAG-3’ 
PCK1 forward 5’-CTGCCCAAGATCTTCCATGT-3’ 
PCK1 reverse 5’-CAGCACCCTGGAGTTCTCTC-3’ 
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3.8 Figures 
 
  
 
Figure 3.1 β2AR and M2R colocalize a shared population of endosomes 
Cells co-expressing HA-β2AR and FLAG-M2R were labeled with fluorescently conjugated HA and FLAG antibodies.  
a. Cells were treated with 10 μM Isoproterenol and 10 μM Carbachol for 30 minutes. b & c. Cells were also transfected 
with the early endosome marker, EEA1-DsRed. Cells untreated (b) and treated with 10 μM Isoproterenol and 10 μM 
Carbachol for 30 minutes (c). d-f. Cells transfected with markers for early recycling endosomes (d, Rab4-mCherry), late 
endosomes (e, Rab7-EGFP), and perinuclear recycling endosomes (f, Rab11-EGFP), were treated with 10 μM 
Isoproterenol and 10 μM Carbachol for 30 minutes. 
 119 
  
 
Figure 3.2 M2R colocalizes with activated β2AR and Gs at endosomes 
Cells co-expressing HA-β2AR and FLAG-M2R were labeled with fluorescently conjugated HA and FLAG antibodies. 
Cells were additionally transfected with nanobodies that mark activated β2AR, Nb80-EGFP (a & b) and activated Gαs, 
Nb37-mCherry (c). Cells were either untreated (a) or treated with 10 μM Isoproterenol and 10 μM Carbachol for 30 
minutes (b & c). 
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Figure 3.3 Characterization of M2R internalization 
M2R internalization was characterized using a flow cytometric assay detecting cell surface receptors (a, b, g) and by 
spinning disk confocal imaging (e). a. Wildtype M2R internalization at 5, 10 and 30 minutes after 10 μM Carbachol 
addition. b. M2R internalization when endocytosis is blocked using either Dyngo-4A (dynamin inhibitor) or CHC17 siRNA 
(clathrin siRNA). p = 0.0002 for Control vs Dyngo-4A; p < 0.0001 for Control vs CHC17 siRNA; p = 0.8468, ns, for 
Dyngo-4A vs CHC17siRNA, by ordinary one-way ANOVA, Sidak’s multiple comparisons test. c. Cartoon of methods of 
endocytic blockade used in b. d. Cartoons of M2R mutants, intracellular loop 3 is highlighted between the two red 
markers. M2R Δi3 mutant has residues 232-372 in intracellular loop 3 deleted. M2R NC8 mutant has two clusters that 
represent phosphorylation sites. Ser/Thr residues in these clusters are mutated to Ala. f & g. M2R wildtype and mutant 
stable cell line characterization. f. Receptor level expression is measured by labeling cell surface receptors and 
compared across wildtype M2R and internalization mutant M2R stable cell lines. data are mean ± stdev. g. M2R 
internalization of wildtype and internalization mutant stable cell lines are measured after 30 minute treatment with 10 μM 
Carbachol. p < 0.0001 for M2R wildtype vs both internalization mutantsl p = 0.9021, ns, for M2R Δi3 vs M2R NC8, by 
ordinary one-way ANOVA, Sidak’s multiple comparison’s test. Data are mean ± sem, except in f, data are mean ± 
stdev. 
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Figure 3.4 M2R inhibition of β2AR acute cAMP signaling 
Cells stably expressing FLAG-M2R (wildtype and internalization mutants). a & b. cAMP was measured using the cAMP 
luminescence assay. a. Cells were treated with 100 nM Iso or 100 nM Iso and 10 μM Cch and imaged for 20 minutes. 
Gray region represents p > 0.05 by two way ANOVA, Sidak’s multiple comparison’s test. b. Cells were pretreated with 
DMSO or 30 μM Dyngo-4A, then cells were treated with 100 nM Iso or 100 nM Iso and 10 μM Cch. Maximum 
luminescence from each condition was normalized to the maximum luminescence from the Control (DMSO) 100 nM Iso 
condition. p = 0.0052 for DMSO Iso vs Iso Cch; p = 0.2428, ns, for Dyngo-4A Iso vs Iso Cch by ordinary one-way 
ANOVA, Sidak’s multiple comparison test. c. cAMP was measured using a cAMP homogenous time resolved 
fluorescence assay. Cells were pretreated with DMSO or 30 μM Dyngo-4A, then cells were treated with 100 nM Iso or 
100 nM Iso and 10 μM Cch for 30 minutes in IBMX. Amount of cAMP produced was normalized to the amount of protein 
per sample. d & e. cAMP was measured using the cAMP luminescence assay. Cells were treated with 100 nM Iso or 100 
nM Iso and 10 μM Cch for 30 minutes. d. Maximum luminescence normalized to the maximum luminescence of 100 nM 
Iso. e. Inhibition by wildtype M2R and M2R internalization mutants are plotted. Data are mean ± sem. 
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Figure 3.5 M2R inhibition of β2AR-induced PCK1 transcription is dependent on the i3 loop 
Cells were treated with agonists for 2 hours. qRT-PCR was performed on samples from these cells with primers for 
PCK1 and GAPDH. a. Cells expressing FLAG-M2R were pretreated with DMSO or Dyngo-4A before 100 nM Iso 
treatment. p = 0.0147 by two-tailed, paired, t-test. b. Cells expressing FLAG-M2R were treated with 100 nM Iso or 
100 nM Iso and 10 μM Cch. p = 0.0002 by two-tailed, paired, t-test. c. Cells expressing FLAG-M2R (wildtype, Δi3 or 
NC8) were treated with 100 nM Iso or 100 nM Iso and 10 μM Cch. p < 0.0001 for M2R vs M2R Δi3; p = 0.3895, ns, 
for M2R vs M2R NC8; p < 0.0001 for M2R Δi3 vs M2R NC8, by ordinary one-way ANOVA, Sidak’s multiple 
comparisons test. Data are mean ± sem. 
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Figure 3.6 M2R inhibition of β2AR-induced PCK1 transcription is endocytosis independent 
Cells were stably expressing FLAG-M2R wildtype (a), M2R Δi3 (b), or M2R NC8 (c), were pretreated with DMSO or 
Dyngo-4A for 15 minutes and then treated with 100 nM Iso or 100 nM Iso and 10 μM Cch for 2 hours. qRT-PCR was 
performed on samples from these cells with primers for PCK1 and GAPDH.  
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Figure 3.7 Model of functional antagonism between β2AR and M2R 
β2AR stimulates the production of cAMP through adenylyl cyclase at the plasma membrane. After endocytosis, β2AR 
continues to produce cAMP. A downstream consequence of the β2AR cAMP signaling cascade is the phosphorylation of 
CREB and the induction of PCK1 transcription. PCK1 transcription is strongly induced when endocytosis is allowed (solid 
arrows) and weakly induced when endocytosis is inhibited (dashed arrows). M2R inhibits adenylyl cyclase production of 
cAMP at the plasma membrane. M2R is able to inhibit β2AR-stimulated PCK1 transcription, however this inhibition does 
not require M2R to be at the plasma membrane. a. M2R strongly inhibits global cAMP from the plasma membrane. b. 
Adenylyl cyclase (AC) trafficking is inhibited through Gαi activation at the plasma membrane. c. M2R intracellular loop 3 
(i3) is required for inhibition of β2AR-stimulated PCK1 transcription. M2R i3 may recruit regulators of cAMP for inhibition 
of β2AR-stimulated PCK1 transcription. 
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Chapter 4: Tools for studying GPCRs 
 
 
 
 
 
 
 
  
 126 
4.1 Overview 
As G protein-coupled receptor (GPCR) endosomal signaling through G proteins is a new area of 
cell biology, the field requires the development of new tools in order to study this localized 
signaling. Recent tools that have proven useful in studying GPCR endosomal signaling are 
conformation biosensors for use in detecting activated GPCRs and G proteins. Expansion of this 
tool set to other proteins involved signaling would be helpful in detecting where activated proteins 
are and locations important for this specialized signaling. Additionally, clever pharmacological 
strategies have been used to activate or turn off signaling from certain membranes by pairing 
agonists and antagonists with different membrane permeabilities. However, not all GPCRs have 
pairs of agonists and antagonists with these properties. Another way we can interrogate signaling 
is by targeting previously described biosensors to different locations in the cell. Lastly, caveats to 
my work are that they use overexpressed receptors and saturating amounts of agonists. We can 
easily decrease the amount of agonist used but decreasing receptor expression can be more 
difficult when strong promoters such as CMV generally are found and used in commercial 
plasmids. Here, we use a previously published method to easily introduce plasmids that have been 
optimized to reduce receptor expression by weak promoters and destabilization elements and 
briefly characterized these low expressing receptor plasmids in our assays. 
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4.2 Nanobody biosensors 
Nanobodies are single chain and single domain camelid antibodies that are sensitive to specific 
protein conformations. Nanobodies have been previously used to stabilize ligand bound G protein-
coupled receptors for structural studies (Rasmussen, Choi, et al., 2011; Rasmussen, DeVree, et 
al., 2011) and have been adapted as conformational biosensors with the addition of a fluorescent 
protein to detect activated GPCRs and G protein (Irannejad et al., 2013; Stoeber et al., 2018). 
Here, we aimed to adapt previously published nanobodies and nanobody biosensors to activated 
M2 muscarinic acetylcholine receptor (M2R) and Gαi protein (Kruse et al., 2013).   
 
4.2.1 Activated M2 muscarinic acetylcholine receptor nanobody biosensor (Nb9) 
To begin development of an M2R nanobody biosensor, we received the nanobodies that detect 
activated M2R, Nb9-1, Nb9-8, and Nb9-20, from the Kobilka lab. All three nanobodies were 
amplified and cloned into pEGFP-N1 and pEGFP-C1. 
 
We tested the nanobody biosensor’s ability to detect M2R by transfecting cells with 1 μg FLAG-
M2R and 100 ng Nb9-EGFP and looked for a redistribution of both receptor and nanobody after 
the addition of carbachol, an M2R agonist. We tested these nanobody biosensors using both total 
internal reflection fluorescent (TIRF) and spinning disk confocal microscopy, using β2AR and Nb80-
EGFP as a positive control. Prior to imaging, receptors were labeled with fluorescent-conjugated 
anti-FLAG (M1) antibody. Before carbachol addition, the nanobody was diffuse in the cytoplasm 
and the receptor was primarily at the cell surface. After 10 μM carbachol addition, there was very 
little change in the distribution of Nb9 (Figure 4.1). Because there was no Nb9-EGFP detected at 
the plasma membrane where we know M2R functions, we suspected that Nb9-EGFP as a 
conformation biosensor was not working. 
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Some optimization of the nanobody biosensors, Nb9-1, Nb9-8, and Nb9-20 was attempted. 
These strategies included switching the location of the EGFP to on the N-terminus, adding different 
sized flexible linkers between Nb9 and EGFP (1x, 3x and 5x GGS), and the use of pertussis toxin. 
With the change in location of EGFP and adding flexible linkers, our rational was that maybe EGFP 
was somehow hindering Nb9 binding, and so changed the location and increased the distance 
between Nb9 and EGFP to test this hypothesis. We chose to use pertussis toxin as a way to 
hinder Gαi binding because 1) Nb9 binds similarly to M2R as Gαi and 2) pertussis toxin ADP-
ribosylates the fifth to last residue on Gαi. This was our strategy to either decrease potentially 
precoupled M2Rs, or to prevent Gαi from blocking available M2Rs to bind. Unfortunately, changes 
either failed localize Nb9-EGFP to the plasma membrane (consistent with the initial generation of 
Nb9-EGFP biosensors), or were not reproducible. We hypothesize that a disulfide bridge in Nb9 (all 
 
Figure 4.1 Development and results of activated M2R nanobody biosensors 
a & b. TIRF analysis of receptor and Nb-EGFP after agonist addition. c-f. Cells overexpressing receptor and Nb-EGFP 
were treated with agonist (10 μM isoproterenol or 10 μM carbachol). Subcellular localization of both receptor and Nb-
EGFP were qualitatively analyzed. 
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variants) is important in the stabilization of the nanobody, and in the reducing environment of the 
cell, the disulfide bridge is broken and the structure of the nanobody is altered.  
 
4.2.2 Adapting activated Gαs Nb37 as an activated Gαi nanobody biosensor  
Heterotrimeric G proteins, first 
discovered decades ago, have since 
been well studied and characterized in 
their role and importance in signal 
transduction (Gilman, 1987). The G 
protein subtypes have different lipid 
modifications which are known to be 
important in regulating their cellular 
localization and function (Wedegaertner, 
Wilson, & Bourne, 1995). The last five residues of a Gα protein is important in which GPCR it 
couples to (Liu, Conklin, Blin, Yun, & Wess, 1995). We used this characteristic in our strategy for 
adapting Nb37-EGFP as a Gαi nanobody biosensor. We generated a construct called Gαsi5, where 
we took the Gαs protein and replaced the last five residues with the last five residues from Gαi. We 
then expressed this chimeric G protein along with Gβγ, Nb37-EGFP and M2R and looked at 
whether localization of Nb37-EGFP changed after carbachol activation of M2R (Figure 4.2). 
 
  
 
Figure 4.2 Adapting Nb37-EGFP for activated Gαi by using 
chimeric Gαsi5 
Cells overexpressing FLAG-M2R, Nb37-EGFP, Gαsi5, Gβ and Gγ 
were imaged by spinning disk confocal. Cells were imaged before 
carbachol addition (a) and 30 minutes after (b) 10 μM carbachol 
treatment. 
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4.3 Targeted cAMP FRET sensors 
Previously, cAMP Förster Resonance Energy Transfer biosensors were developed using Epac or 
indicator of cAMP using Epac (ICUE) as the cAMP binding domain. Upon cAMP binding, FRET 
would decrease. Localized cAMP FRET sensors have been previously used to detect cAMP at the 
plasma membrane, in the nucleus and at the Golgi (DiPilato, Cheng, & Zhang, 2004; Godbole, 
Lyga, Lohse, & Calebiro, 2017; Sample 
et al., 2012). Our initial goal was to 
detect cAMP being produced from the 
endosome. We hypothesized that there 
would be a delay in endosomal cAMP 
production relative to plasma 
membrane cAMP production because 
the receptor and activated G protein 
would take time to traffic to the 
endosome.  
 
To generate the constructs, we first 
started with the previously published 
CFP-ICUE2-Citrine construct (Violin et 
al., 2008). We used targeting 
sequences lyn11 and 2xFYVE (Hrs) that 
were previously used to target bacterial-
derived photoactivatable adenylyl 
cyclase to the plasma membrane and 
 
Figure 4.3 Targeting cAMP FRET sensors to the plasma 
membrane and the endosome 
a. Cells transfected with CFP-ICUE2-Citrine, lyn11-CFP-ICUE2-
Citrine or 2xFYVE-CFP-ICUE-Citrine and localization of each 
construct was checked by widefield epifluorescence microscopy. 
Quantitative analysis of the targeted cAMP FRET sensors in 
plasma membrane (lyn11-CFP-ICUE2-Citrine, b) and endosome 
(2xFYVE-CFP-ICUE2-Citrine, c) targeted cAMP FRET sensors.  
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the endosome (Tsvetanova & von Zastrow, 2014). We first compared the localization the targeted 
cAMP FRET sensors to the parent cytoplasmic cAMP FRET sensor by widefield epifluorescence 
microscopy (Figure 4.3a). We found that there was some diffuse fluorescence in the cytoplasm, but 
the targeted constructs did localize to the plasma membrane and the endosome. 
 
Next, we investigated the dynamics of cAMP production in the plasma membrane and endosome 
targeted cAMP FRET sensors (Figures 4.3b&c). We found that both targeted cAMP FRET sensors 
behaved very similarly to the cytoplasmic cAMP FRET sensor (data not shown). We also did test 
these targeted sensors at room temperature and with saturating amounts of agonist and PDE 
inhibitor (10 μM isoproterenol and 100 μM IBMX). In both cases, we did see a larger FRET change 
after agonist was added, however the kinetics of each sensor remained similar.  
 
Because we did not see a change in kinetics between the targeted sensor, we suspected this was 
due to the diffusibility of cAMP and the simplicity of the organization in our HEK293 cells. Previous 
studies in cardiomyocytes have shown spatial definition of cAMP (Nikolaev, Bünemann, 
Schmitteckert, Lohse, & Engelhardt, 2006). Cardiomyocytes are highly structured and organized 
cell in comparison to HEK293 cells, this could help explain the differences in our cAMP FRET 
sensor results. 
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4.4 Reducing overexpressed receptor levels 
We used the ePiggyBac transposon gene delivery system to reduce protein expression by using a 
weak promoter (Ubiquitin C, UbC) and mRNA destabilizing elements (Alexander et al., 2019; 
Lacoste, Berenshteyn, & Brivanlou, 2009; Qin et al., 2010). Here, generated low expressing M2R 
receptor stables and show reduced expression compared to the original stable cell line, and 
conservation of M2R characteristics (internalization and inhibition of cAMP signaling).  
 
To generate our M2R constructs, we first obtained destination vectors (pDEST ePiggyBac-UbC, 
pDEST ePiggyBac UbC-2xDE, pDEST ePiggyBac UbC-4xDE) from the Weiner lab. We cloned 
M2R IRES Neo and M2R NC8 IRES Neo into an entry vector, pENTR1A. Then using the Gateway 
cloning system, we switched our cassettes M2R IRES Neo or M2R NC8 IRES Neo into the 
destination vector to generate ePiggyBac UbC M2R IRES Neo and other variants. We then 
generated stable cell lines from these plasmids. 
 
We tested these stable cell lines by first comparing their receptor expression levels to our 
previously generated M2R stable cell line (Figure 4.4a). We found that receptor expression was 
reduced in cells where M2R was promoted by UbC and expression was even further reduced with 
more destabilization elements (DE) and less ePiggyBac transposon expressed. These stable cell 
lines were also checked if they maintained expected internalization abilities. As expected, all the 
wildtype M2R cell lines were able to internalize to a significant degree after 30 minutes of 10 μM 
carbachol treatment (Figure 4.4b). Additionally, M2R NC8 cell lines behaved as expected with 
reduced internalization after 30 minutes of 10 μM carbachol treatment (Figure 4.4b). Lastly, the 
ability for these reduced expression cell lines to inhibit β2AR-stimualted PCK1 transcription was 
examined. We found that M2R with four destabilization elements was still able to inhibt β2AR-
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stimualted PCK1 transcription, and that this was verified to be dependent on the activation of Gαi 
by the addition of pertussis toxin (Figure 4.4c). Similarly, M2R NC8 with four destabilization 
elements also maintained the ability to inhibit β2AR-stimualted PCK1 transcription that was Gαi-
dependent (Figure 4.4d). Using the ePiggyBac gene delivery system in combination with elements 
to reduce expression (weak promoter and destabilization elements) worked effectively to reduce 
M2R expression levels without compromising function. 
   
 
Figure 4.4 Characterization of stable cell lines with reduced receptor expression 
a. Receptor expression of stable M2R cell lines generated using the ePiggyBac system. 1:1 and 1:2 ratios designates 
amount of receptor:ePiggyBac transposon constructs during transfection. b. M2R receptor internalization. Lowest 
expressors of M2R and M2R NC8 were both tested for inhibition on β2AR-stimulated PCK1 transcription. Pertussis 
toxin added to check specificity of inhibition. 
 134 
4.5 Detecting activated β2 adrenergic receptors in zebrafish 
The recent studies using conformational biosensors has proven how powerful these nanobody 
biosensor can be. These nanobody biosensors have been found to be rather specific, as they do 
bind to other receptors of the same type - Nb80 does not detect other Gαs activated GPCRs, e.g. 
D1 dopamine receptor (Irannejad et al., 2013). However, Nb80 detects human β1AR in addition to 
β2AR, likely because they are approximately 66% homologous.  
 
To expand the use of nanobody biosensors for study within organisms, we asked whether the 
β2AR-specific Nb80 could detect zebrafish βARs. Zebrafish have one β1AR (adrb1) and two 
β2ARs (adrb2a and adrb2b), and these βARs are 60% or more homologous to their human 
analogs. Previous work has been done characterizing different βAR agonists by expressing 
zebrafish βARs in HEK293 cells (Steele et al., 2011). Here, we generate FLAG-tagged zebrafish 
βAR constructs (FLAG-zfβAR) by isolating genomic DNA from a zebrafish tail fin sample. Like many 
GPCRs, none of the zebrafish βARs had introns, and so the cDNA was directly amplified from the 
genomic DNA and cloned into pcDNA3 with an N-terminal FLAG tag. Only zfβ1AR and zfβ2ARb 
were cloned, and mistakenly a stop codon was forgotten, resulting in a minorly larger protein. 
These constructs were recloned by others and the same trafficking behavior was seen for both 
receptors (personal communication, R. Irannejad 2019). 
 
We transfected zfβARs and Nb80-EGFP and imaged their localizations in the cell after 30 minutes 
of 10 μM isoproterenol by spinning disk confocal (Figures 4.5a&b). We found that zfβ1AR 
internalized after isoproterenol addition and that Nb80-EGFP, instead of being diffuse in the 
cytoplasm, exhibited puncta primarily at the perinuclear region that colocalized with some zfβ1ARs. 
With zfβ2Arb, we found minimal internalization with zfβ2ARb primarily at the plasma membrane. 
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Nb80-EGFP in this case 
remained diffuse in the 
cytoplasm and did not 
seem to colocalize with 
Nb80-EGFP.  
 
Other work was also 
done to express Nb80-
EGFP in zebrafish. We 
cloned a construct that put Nb80-EGFP under the cmlc2 zebrafish cardiac promoter and injected 
DNA into embryos. We found that the heart was faintly EGFP positive, but could not detect any 
changes after isoproterenol addition. Our major problems with this experiment were that 1) fish 
expressing Nb80-EGFP seemed to have development defects and 2) we had some issues with 
mounting larva and for imaging. Our rationale for our first problem was that high expression of 
Nb80 is known to be toxic and capable of blocking βAR signaling, overexpression of Nb80 in the 
heart may have caused development defects. To prevent this, we additionally generated a 
construct with a light inducible promoter for Nb80-EGFP. This system, TAEL, was previously 
described and used in zebrafish ((Motta-Mena et al., 2014; Reade et al., 2017). This construct yet 
to be tested. 
 
 
 
  
 
Figure 4.5 Detecting activated βARs in zebrafish 
 FLAG-tagged zfβARs, zfβ1AR (a) or zfβ2ARb (b), and Nb80-EGFP were transfected 
into HEK293 cells and imaged by spinning disk confocal after 30 minutes of 10 μM 
isoproterenol treatment. 
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Chapter 5: Discussion 
 
One day, in retrospect, the years of struggle will strike you as the most beautiful. 
Sigmund Freud 
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5.1 Overview 
The first papers describing G protein-coupled receptor signaling at the endosome through G 
protein activation were first published 10 years ago. In the past decade, much work has been done 
to understand more about the function and regulation of endosomal signaling by GPCRs. This 
dissertation explored how the endosome can promote such a specific and selective signal through 
cAMP-dependent transcription and investigated the consequences integrative cellular signaling 
from multiple receptors active at multiple locations. From Chapter 2, we identify that the key point 
in the cAMP signaling cascade in promoting cAMP-dependent transcription is nuclear PKAcat 
accumulation. In Chapter 3, we find that the M2R can inhibit β2AR-stimulated cAMP-dependent 
transcription but it is not necessary for M2R to be at the same membrane as β2AR. Together, our 
work in understanding endocytic control of cAMP-dependent transcription provides insight into 
how the cAMP signaling cascade is propagated and the importance of endocytosis. 
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5.2 Mechanism of nuclear accumulation of PKAcat  
The role that PKAcat plays in the cAMP signaling cascade is to phosphorylate substrates in the 
cytoplasm and nucleus. PKAcat phosphorylates CREB in the nucleus which results in the induction 
of CRE-mediated gene transcription. There are two ways for PKA to localize in the nucleus. The 
first is through diffusion of PKAcat after liberation from PKAreg as a result of cAMP elevation 
(Harootunian et al., 1993). The second is through nuclear-localized AKAP95 microdomains 
containing both PDE4 and PKA holoenzyme where nuclear PKAcat at the AKAP95 microdomain is 
activated under high levels of cAMP (Clister et al., 2019). 
 
In Chapter 2, we find that nuclear accumulation of PKAcat is the key step in promoting cAMP-
dependent transcription. This is consistent with previous work that found that nuclear import of 
PKAcat was the rate-limiting step in the cAMP-dependent transcriptional pathway (Hagiwara et al., 
1993). Our findings suggest that without endocytosis, much less PKAcat is accumulated in the 
nucleus over tens of minutes. We emphasized that somehow endocytosis is promoting nuclear 
PKAcat accumulation although through unknown mechanisms. Here, I speculate the possible 
mechanisms for nuclear accumulations of PKAcat in more detail.  
 
In Chapter 2 we found that there was a divide in the cAMP signaling cascade components and 
how greatly they were affected by the inhibition of endocytosis. On one side of the divide are two 
components, the first ones we studied that are representative of global cAMP and cytoplasmic 
PKAcat. Neither global cAMP nor cytoplasmic PKAcat were greatly affected by endocytic 
blockade. However, on the other side of this divide are the more specific localized responses of 
nuclear PKAcat, CREB phosphorylation and PCK1 transcription, all of which were affected greatly 
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by endocytic blockade. Interestingly, these components of the cAMP signaling cascade reside in 
the nucleus. How could such a selective signal be produced?  
 
We first hypothesize a simple idea based on fundamental diffusion principles of how the cAMP-
dependent transcriptional response is selectively generated by endocytosis. We propose that the 
combination of global cAMP (i.e. primarily produced at the plasma membrane) and local cAMP 
(e.g. endosome source) are important in deciding whether nuclear accumulation of PKAcat occurs 
during the plateau phase of cAMP signaling.  
 
Global cAMP defines the ability of PKAcat to diffuse (speed and distance) in the cell. When the 
diffusion rate of a protein is fast, it does not concentrate greatly anywhere in the cell as it quickly 
distributes equally and evenly (Figure 5.1a; Berg, 1993). However, when the diffusion rate of a 
protein is slow, it is most concentrated next to its source and decreases in a concentration 
gradient as it moves away from its source (Figure 5.1a). The distance of this gradient is determined 
by the diffusion rate, and consequently the slower the rate the longer the distance (Figure 5.1b).  
 
Figure 5.1 Distance and concentration determined by diffusion rates 
a & b. Dependence of distance traveled and relative concentrations on diffusion rate. a. We used the equation 
determining the concentration of a molecule due to a pulse with a time of t, C(r,t) = (i/4πDr) erfc (r/((4Dt)0.5)) where D is 
diffusion, r is distance (See Appendix C; Berg 1993). b. We used the equation determining the concentration of a 
molecule when a pulse is long enough that the concentration approaches a steady-state value, C(r,t) = (i/4πDr) where D 
is diffusion, r is distance (See Appendix C; Berg 1993) c. Bleaching recovery from a 30 μm2 rectangular FRAP spot. We 
used the recovery equation adapted for a rectangular bleaching spot I(t) = I(∞) (1- (w2(w2 + 4 πDct)-1)-0.5)  where w2 is the 
area of the rectangular bleaching spot (30 μm2 for our experiments) and Dc is diffusion coefficient (See Appendix C; 
Blumenthal et al., 2015). 
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If there is any free PKAcat, it would readily be captured by a PKAreg as PKAreg exists in excess of 
PKAcat in the cell (Walker-Gray et al., 2017). When there are high levels of global cAMP, all or most 
of the PKAreg subunits are bound with cAMP, and consequently PKAcat instantly binds PKAreg 
and readily unbinds (Cheng et al., 2001; Zawadzki & Taylor, 2004). Therefore, PKAcat spends very 
little time on PKAreg and behaves similarly to a freely diffusing protein (Swaminathan et al., 1997). 
We speculate that when there are low levels of global cAMP, the behavior of PKAcat is somewhere 
in between. There is a mixture of PKAreg subunits that are bound with cAMP so PKAcat can be 
released and a population of free PKAcat exists. This free PKAcat can freely bind PKAreg, and will 
unbind with a slower timeframe than when there are globally high cAMP levels. This results in 
effective diffusion because PKAcat moves in the cell at a slowed diffusion rate due to the on and 
off interactions with multiple PKAreg subunits. 
 
Local cAMP determines the amount of PKAcat that is released. Endosomes exist throughout the 
cytoplasm, and such local sources of cAMP production can release PKAcat in the cytoplasm to 
diffuse in the cell. When global cAMP is at a low level, PKAcat can diffuse further from its original 
location, together with local cAMP production by endosomes, an increased the pool of slowly 
diffusing PKAcat that can enter the nucleus.  
 
Our data supports this hypothesis as we see both a slowed mobility of PKAcat from our FRAP 
experiment (Figure 2.6). We estimate this slowed mobility to be 10-100 fold slower than estimated 
free diffusion in the cytoplasm (~30 μm2/s, Swaminathan et al., 1997). At this slowed diffusion rate, 
PKAcat concentrated at the perinuclear region can traverse the distance necessary to enter the 
nucleus (Figure 5.1c; Blumenthal et al., 2015) .  
 
 144 
We additionally propose another method in which nuclear accumulation of PKAcat is promoted by 
endocytosis. Nuclear accumulation of PKAcat can be regulated by nuclear import or nuclear 
export. No known nuclear localization sequence has been found in PKAcat, but A kinase 
interacting protein 1 (AKIP1) and Asn2 (the non-deamidated form of PKAcat) have been suggested 
to play a role in targeting PKAcat to the nucleus (Pepperkok et al., 2000; Sastri et al., 2005). 
Additionally, protein kinase inhibitor (PKI), a known regulator of PKAcat, inhibits PKAcat through 
binding and nuclear export (Wen et al., 1995). Endocytosis may modulate these events to promote 
PKAcat nuclear import or nuclear retention. 
 
Lastly, it is possible that cytoplasmic PKAcat is affected when endocytosis is blocked, however we 
cannot detect these differences with our current imaging assays. It is possible that these 
differences are unseen due to a lack of spatial resolution or low signal to noise. One way to test 
whether there is a population of endosomes near the perinuclear region important in contributing to 
nuclear accumulation of PKAcat is to use inverse FRAP. Here we would photobleach an area of 
the cytoplasm that did not contain perinuclear PKAcat and observe the perinuclear region for a 
pattern of stable / unstable PKAcat. If a pattern emerged, this would indicate the presence locally 
released PKAcat by endosomes.  
 
There remains much to be explored in understanding the mechanism in PKAcat nuclear 
accumulation. Our findings determined that nuclear accumulation of PKAcat is an important key 
step in promoting endocytic control of cAMP-dependent transcription. It is possible that there are 
multiple mechanisms of nuclear PKAcat activity at work, and dependent on the cell type and 
organization, one or a combination of these mechanisms could be working together. Work with the 
TSHR has found an importance for PKA localized at the Golgi (Godbole et al., 2017). Additionally, 
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TSHR is a GPCR that has sustained high levels of cAMP. Golgi-localized PKAcat could be working 
in concert with nuclear localized PKAcat (sensitive to high levels of cAMP) to promote an 
endocytosis-sensitive cAMP-dependent transcriptional response. 
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5.3 Integrative cellular signaling 
Multiple G protein-coupled receptors are often involved in a single physiological process, as a 
robust and important way to regulate such a physiological response. We have yet to understand 
how functional relationships between receptors are affected by endocytosis and whether 
endosomes provide a privileged location where receptors can have increased or decreased 
modulation of their signal. We have much to understand in how cells interpret and integrate 
multiple signaling responses generated by different inputs and receptors. Our goal was to 
determine how functional relationships between two opposing receptors are regulated as 
receptors signal and traffic from the plasma membrane to the endosome where they may continue 
to signal. We used the β2AR and the M2R as an example of receptors with such a functional 
antagonistic relationship. 
 
Very little has been published with regards to how endosomal signaling affects the functional 
relationship between two GPCRs. One study describes a synergistic effect when the PTHR and 
β2AR are coactivated (Jean-Alphonse et al., 2016). β2AR helps increase cAMP production through 
Gαi activation at the plasma membrane and the subsequent release of Gβγ. Gβγ then localizes to 
the endosome to activate AC2, described to be important for PTHR endosomal signaling, and to 
promote a stronger cAMP response from the endosome. Other studies investigating opposing 
functional relationships have yet to be described and explored.  
 
Our findings describe that M2R may be active at the endosome to inhibit β2AR-stimulated cAMP-
dependent transcription, but activity at the endosome is not required for M2R inhibition. M2R is 
capable of inhibiting the β2AR cAMP signaling cascade from the plasma membrane. These results 
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are consistent with PTHR and β2AR study, such that a receptor does not need to be at the 
endosome to modulate the endosomal GPCR’s response. 
 
We amend our previous hypothesis from Chapter 2 and Chapter 5.2, and propose that M2R 
inhibits global cAMP strongly from the plasma membrane to prevent the strong induction of cAMP-
dependent transcription by β2AR at the endosome. If M2R reduces the global cAMP level down to 
near basal levels, then PKAcat would not diffuse far with a substantial concentration. To test this, 
we would use the cAMP fluorescence biosensors generated in Chapter 2 to observe cAMP levels 
during the plateau phase when β2AR and M2R were costimulated. We predict that the cAMP 
levels at the plateau phase when both receptors are stimulated would be significantly lower than 
when only β2AR was stimulated. Additionally, we could perform the photobleaching experiment in 
cells stimulated with both β2AR and M2R agonists. If this hypothesis is true, we would predict that 
there would very little recovery (similar to basal). 
 
What has been difficult in studying the relationship between M2R and β2AR is that signaling 
cascades get far more complicated the further downstream the cascade you go. There become 
more inputs to promote that downstream signal. For instance, CREB is not only phosphorylated by 
PKAcat, multiple other kinases can phosphorylate CREB from different (non-cAMP) signaling 
pathways (Du & Montminy, 1998; Naqvi et al., 2014; Shi et al., 2012). Stimulation of M2R alone 
can increase CREB phosphorylation, which can make interpretation of experiments coactivating 
β2AR and M2R difficult. There is a great need for more sensitive tools and methods will be 
necessary to investigate the functional relationships between receptors at the endosome. 
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5.4 Open questions in the field of endosomal signaling 
The goal of this dissertation was to clarify how endosomal signaling promotes a selective signal 
and how or whether that selective signal could be regulated by another receptor. As always with 
science, you might answer one question but find yourself asking 10 new ones. We found that 
PKAcat nuclear entry was a key step in promoting the endosomal signaling, however the 
mechanism in how endocytosis promotes remains unanswered. We additionally conclude that 
M2R can inhibit the β2AR endosomal signal, but M2R internalization is not required for this 
inhibition. More work needs to be done to determine mechanism of regulation by M2R at the 
plasma membrane on the β2AR endosomal signal. These possibilities are discussed previously in 
Chapters 5.2 and 5.3, here we discuss open questions that remain unanswered in the field. 
 
Though GPCR endosomal signaling is now widely accepted due to the great body of work in the 
past few years, we still have many unanswered questions. What components generate the 
endosomal signal? How is the endosomal signal regulated? What are the prerequisites for a GPCR 
to signal from the endosome? 
 
Some effectors in the Gs and Gi signaling pathways have been identified. There is some evidence 
that suggests the importance of different adenylyl cyclases and their role in endosomal signaling. 
Multiple adenylyl cyclases have been found at intracellular membranes, including the endosome. 
Work with the TSHR found AC3 and AC5/6 at the plasma membrane and at intracellular vesicles 
(Calebiro et al., 2009). AC5 has also been observed at intracellular vesicles thought to be 
endosomes containing D1 dopamine receptor (Kotowski et al., 2011). Soluble adenylyl cyclase 
(sAC) has been found to be important for endosomal signaling by corticotropin-releasing hormone 
receptor 1 (CRHR1), because the inhibition of both sAC and endocytosis when CRHR1 was 
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activated did not produce an additive effect (Inda et al., 2016). AC2 has also been implicated in 
endosomal signaling of PTHR and PTHR and β2AR primarily through cAMP signaling experiments 
(Jean-Alphonse et al., 2016). Work in our lab has also identified AC9 present at and trafficking to 
the endosome with signaling consequences when AC9 trafficking is inhibited (Lazar, 2019). Many 
of these studies combine localization results with indirect signaling results to suggest which 
adenylyl cyclases may be playing a role in their signaling pathway.  
 
There have been some ideas proposed in how the endosomal signal is shut off, but endosomal 
signal termination remains unclear. It is possible that receptors undergo their normal shutoff 
mechanism through phosphorylation of the receptor and the binding of arrestin to inhibit G protein 
interaction. Or that through the continuation of their normal trafficking itineraries (recycling, 
degradation) will eventually results in signal termination.  
 
Although our data do not indicate whether M2R is active at the endosome or not, I curiously began 
to question how or why a receptor might not signal from the endosome. A possibility is related to 
one of the termination mechanisms described above, arrestin (or any other protein) binding can 
precludes G protein binding and therefore, G protein activation. M2R for instance, binds arrestin 
strongly at the endosome (Figure 5.2). 
Paradoxically, other GPCRs known to signal 
from the endosome, such as V2R, also bind 
arresting strongly at the endosome (Pavlos & 
Friedman, 2016). V2R however has its 
phosphorylation sites on its C-terminal tail and can interact with arrestin in the “tail” conformation 
without engaging the transmembrane core (Cahill et al., 2017). Phosphorylation sites for M2R 
 
Figure 5.2 M2R colocalizes with arrestin-3 at endosomes 
Cells stably expressing FLAG-M2R and transfected with Arr3-
EGFP were imaged by spinning disk confocal after 30 minutes 
of 10 μM Carbachol. 
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important for desensitization reside in intracellular loop 3, and although its unknown if M2R can 
engage with arrestin in the “tail” conformation, binding arrestin may prevent G protein from 
engaging with the receptor to result in G protein activation.  
 
Methods and tool development will be critical and important in studying and understanding 
endosomal signaling in different receptors and cellular contexts. Conformational biosensors have 
already proven to be extraordinarily useful, but it may be difficult to generate and find a useful and 
specific nanobody, despite the efforts that have been done to do so (Mcmahon et al., 2017). Non-
nanobody conformational biosensors have also been generated and adapted from structural 
studies for use in visualizing active GPCRs (Wan et al., 2018). Additionally, the development of 
biosensors to study signaling live with high spatial and temporal resolution will greatly add depth to 
our endosomal signaling knowledge.  
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A. cAMP Dual Luciferase assay 
Materials 
pSF CMV GloSensor20F IRES Rluc stable cell line, previously generated in Chapter 2 from 
pGloSensor20F, Promega and pSF CMV EMCV Rluc, Boca Scientific 
 
Coelenterazine, Gold Biotechnology CZ2.5: Stock is 1 or 2 mM in ethanol. 
 
D-Luciferin, Na Salt, Gold Biotechnology LUCNA-1g: Stock is 100 mM in 10 mM HEPES 
 
Braden’s Stop buffer (1x) 
25 mM HEPES, pH 7.4 
1 mM EDTA 
0.4 mM DTT 
0.2% TritonX-100 
2% Glycerol 
 
Imaging media 
DMEM without phenol red (Gibco, 31053) 
30 mM HEPES 
 
24 well plate 
 
Protocol 
Day 0: Seed cells. 
1. Plate cells in 10 cm dish at 60-70% confluency. 
 
Day 1: Transfect cells 
Transfect cells with dual luciferase 2 μg GloSensor plasmid (pSF CMV Glo20F IRES Rluc), or use 
stables. 
  
Day 2: Assay day 
1. Lift transfected cells and spin down in cell culture centrifuge at ¾ speed for 10 minutes. 
2. Resuspend cells in 4 mL of imaging media. 
3.  Add luciferin, 64 μL 100 mM luciferin to 4 mL cells in imaging media. 
4.  Aliquot 200 μL cells/well into the central 16 wells of a 24 well plate. 
5.  Place cells in incubator for 1 hour. 
6. Prepare for assay 20 minutes before luciferin incubation is up:  
a. Turn on computer, camera and heated chamber. 
b. Make up 2x drugs, and place in incubator to warm. 
7. When ready, take cells and drug mix out of the incubator to the cAMP luminometer. Add 
200 μL drugs to each well and place inside heated chamber and start imaging. 
a. 121 frames (20 minutes), 10 second exposure (10000 ms), continuous intervals. 
8.  While the plate is imaging prepare buffer for coelenterazine.     
a. Prepare Stop buffer (either make fresh or thaw 5x Stop buffer, -80°C.) 
b. After thawed, add coelenterazine for a final concentration of 10 μM coelenterazine 
in stop buffer. 
9. When plate has finished, add 100 μL 5x Stop buffer with coelenterazine (final concentration 
2 μM coelenterazine/well) to each well. 
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10.  Immediately image renilla luminescence. 
a. 5 frames, 10 second exposure, Continuous intervals 
 
Analysis 
1. Generate 4 ROIs for background measurement. 
2. Generate 16 ROIs for each well. 
3. Background subtract each well/frame of the firefly luciferase luminescence. 
4. Background subtract each well for the renilla luciferase luminescence.  
5. Divide firefly luciferase luminescence by renilla luciferase luminescence for each well. 
6. Plot luminescence ratio of firefly/renilla vs time. 
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B. cAMP Homogenous Time Resolved Fluorescence Assay 
B.1 Method 
The original kits were gifted by Nicolas Pierre (CisBio) and instructed for 384 well plates. I adapted 
the protocol for use in white 96 half area well plates. 
 
cAMP Gs Dynamic Kit, CisBio (#62AM4PEB) 
 
New kit reagent preparation: 
Warm reagents to room temperature for 30 minutes before reconstitution. 
 
Anti cAMP Eu3+ Cryptate (K) 5x stock 
Add 1.1 ml water to vial, aliquot 100 μL into microcentrifuge tubes. 
 
cAMP-d2 (d2) 5x stock 
Add 1.1 ml water to vial, aliquot 100 μL into microcentrifuge tubes. 
 
cAMP standard (280 nM) 
Add 0.45 ml water to vial, aliquot 112.5 μL into microcentrifuge tubes. 
 
Keep stocks frozen for 6 months, or one week at 4℃. 
 
Protocol 
Day 0: 
Seed cells into 6 well plate. 
 
Day 1: 
1. Prepare reagents, warm conjugate & lysis buffer to room temperature and thaw cAMP 
standard on ice. 
2. Prepare cells: 
a. Wash cells once with PBS with EDTA, and lift cells (3 wells of a 6 well). 
b. Resuspend cells in 10 mL.  
c. Spin down cells and resuspend in 2 mL media. 
3. While cells are spinning down, prepare standards. 
 
Table B1.1 Preparation of Standards 
Standard Preparation cAMP working solution (nM) [cAMP] (nM) 
Std 7 Reconstituted reagent in water 2848 712 
Std 6 50 μL Std 7 + 150 μL media 712 178 
Std 5 50 μL Std 6 + 150 μL media 178 44.5 
Std 4 50 μL Std 5 + 150 μL media 44.5 11.125 
Std 3 50 μL Std 4 + 150 μL media 11.125 2.78 
Std 2 50 μL Std 3 + 150 μL media 2.78 0.70 
Std 1 50 μL Std 2 + 150 μL media 0.70 0.17 
Std 0 200 μL media 0 0 
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4. Prepare plate for cell treatment 
Table B1.2 Example plate layout 
  1 2 3 4       
A  Std 7 Std 7 neg neg 
B  Std 6 Std 6 cell neg cell neg 
C  Std 5 Std 5 unstim cells unstim cells 
D  Std 4 Std 4 sample 1 sample 1 
E  Std 3 Std 3 sample 2 sample 2 
F  Std 2 Std 2 sample 3 sample 3 
H  Std 1 Std 1 sample 4 sample 4 
I  Std 0 Std 0 sample 5 sample 5 
 
Each well will have 100 μl total at the end of the experiment: 
25 μL media or agonist treatment 
25 μL standard or cells 
25 μL cAMP-d2 in lysis buffer, or just lysis buffer 
25 μL Eu3+ cryptate in lysis buffer 
 
Table B1.3 Components added per well 
Standards Negative control Cell neg control Cell samples 
25 μL Media 25 μL Media 25 μL Media 25 μL Treatment 
25 μL Standard 25 μL Media 25 μL Cells 25 μL Cells 
25 μL cAMP-d2 25 μL Lysis buffer 25 μL Lysis buffer 25 μL cAMP-d2 
25 μL Eu3+-cryptate 25 μL Eu3+-cryptate 25 μL Eu3+-cryptate 25 μL Eu3+-cryptate 
 
There are TWO incubations. For the first incubation (drug treatment), add the reagents in BLUE:  
a. Add 25 μL media to wells that will have standards/controls, OR 25 μl agonist treatment 
to wells with samples. 
b. Add 25 μL of standard or cells to respective wells. 
 
5. Incubate plate for 30 minutes (room temperature or 37℃). 
6. Make working stock solutions of Eu3+-cryptate and cAMP-d2 by diluting 1:4 (100 μL + 400 
μL conjugate and lysis buffer). 
7. Prepare for the second incubation (antibody and cAMP conjugate), add the reagents in RED: 
a. Add 25 μL conjugate & lysis buffer to negative control and cell negative control and add 
25 μL cAMP-d2 (in conjugate & lysis buffer) to the rest of the samples (standards and cell 
samples). 
b. Add 25 μL Eu3+-cryptate (in conjugate & lysis buffer) to all samples. 
8. Incubate for 1 hour at room temperature. (I put it in a drawer.) 
9. Read plate after one hour on the Tecan M200 Infinite Pro using Tecan i-Control. 
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B.2 Analysis 
Data analysis: https://www.cisbio.com/usa/drug-discovery/htrf-ratio-and-data-reduction 
 
Example data: 
317/620 nm 
 Temperature: 22.9 °C  
<> 1 2 3 4 
A 14435 14335 15026 14099 
B 14199 14750 13287 12755 
C 14429 14610 15372 14386 
D 12800 13111 14299 14704 
E 12547 12638 15010 14669 
F 12597 12580 15446 15953 
G 12518 12935 14845 14250 
H 12712 12705 15783 15332 
 
317/665 nm 
 Temperature: 23.2 °C  
<> 1 2 3 4 
A 1139 1112 1089 878 
B 1193 1396 5434 5087 
C 1964 2379 1036 1075 
D 3503 3671 2532 2873 
E 6374 6453 2229 2254 
F 7829 8333 1138 1120 
G 9876 9790 1922 1354 
H 1100 1074 1862 1612 
 
In Microsoft Excel: 
 
1. Determine ratio of 665 to 620 signal. 
 ratio = 	665nm × 10-620nm  
2. Background correct the ratio. 
 Δ	ratio = ratio012 − ratio456  or   Δ	ratio = ratio0789:5 − ratio;5::456 
 
3. For interassay comparison, calculate ΔF and ΔFmax. ∆F = 	 ratio0789:5 − ratio;5::456ratio;5::	456  
Use ∆>∆>max to compare assay to assay. 
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In GraphPad Prism: 
4. For actual concentrations, open a tutorial in Prism “RIA or ELISA: Interpolate unknowns 
from sigmoidal curve” 
5. Put in background corrected ratios for the standard curve and the unknowns. 
6. Calculate log concentration of cAMP. 
7. Interpolate unknowns for standard curve by using 4PL, sigmoidal method. 
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C. Modeling diffusion 
Matlab R2018b code 
 
For Figure 5.1a 
function out = diffusion(D) 
N = 100 % number of ACs on endosome (in molecules) 
i = 30 * N % rate of production assumes kcat 30 sec-1 per Dessauer and 
Gilman 1997 (~agrees with Levitzki 1974 turkey RBC and Takai et al 1974 E 
coli) 
t = 20 % 20 second pulse 
r = linspace(0.01, 0.25, 200); % radius of observer from 10 nm to 250 nm. 
  
out = (i./(4*pi*D*r)).*erfc(r/((4*D*t)^0.5)) % Berg eq 2.9 
outint10 = @(r) (i./(4*pi*10*r)).*erfc(r/((4*10*t)^0.5)) 
q = integral(outint10, 0.00001, 0.1); % sets the reference to 10 um, and 
so divided y by ~220. integrated number is at 100 nm. 
  
plot(r*1000,out/q) 
end 
 
For Figure 5.1b 
function out = diffusion2(r) 
N = 100  % number of ACs on endosome (in molecules) 
i = 30 * N  % rate of production assumes kcat 30 sec-1 per Dessauer and 
Gilman 1997 (~agrees with Levitzki 1974 turkey RBC and Takai et al 1974 E 
coli) 
D = linspace(0.1, 100, 200) % Diffusion constant 0.1 to 100 um^2/s 
r = 0.1 % distance from source, 100 nm 
 
out = (i./(4*pi*D*r)); % Berg eq 2.11 
outint10 = @(r) (i./(4*pi*10*r)); 
q = integral(outint10, 0.00001, 0.1); % sets the reference to 10 um, and 
so divided y by ~220. integrated number is at 100 nm. 
y = out/q 
 
loglog(D,y) 
xlim([0.1, 100]) 
ylim([0.1,100]) 
end 
 
For Figure 5.1c 
function out = rectangular(Dc) 
t= [0:10:300] %time 0 to 300s intervals of 10s 
Ii=1 % plateau, intensity at time infinity, assume full recovery 
A=30 % um2s-1, Area of bleaching region 
% Dc is in um2s-1 diffusion constant 
  
It=Ii*(1-sqrt(A*(A+4*pi*Dc*t).^-1)) % Blumenthal et al. 2015, supplemental 
equation 4 
  
plot(t,It) 
end 
 

